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Abstract 
 
 Colorectal cancer incidence is highly associated with one’s lifestyle, such as lack of 
physical activity, which leads to obesity, smoking habits, and most importantly, diet. Diet is an 
important risk factor for colon carcinogenesis and several studies have shown that high red 
meat and saturated fat intake increases the incidence of this disease significantly. On the other 
hand, a healthy balanced diet with intake of fruits and vegetables can decrease the risk of this 
disease. Dietary strategies for colon cancer chemoprevention, and even during treatment, are 
needed to help reduce the incidence of colorectal cancer. The aim of this work was to 
investigate dietary compounds that can be used in these dietary strategies for colon cancer 
prevention. Also, we initiated the development of new models to be used for compound 
screening processes. 
 Initially, we focused on the effects of two bile acids, deoxycholic acid (DCA), with 
colon cancer promoting capacity, and ursodeoxycholic acid (UDCA), a chemopreventive 
compound, induced in Caco-2 cell line. We found that DCA in fact increase DNA damage and 
apoptosis in Caco-2 cell line. Also, activation of MAPK/ERK and PI3K/AKT pathways was 
also observed. UDCA did not induce DNA damage, but did induce the same activation in the 
signaling pathways. So, it seems that DCA increase cell turnover by increasing apoptosis and 
also cell proliferation in the remaining cells. UDCA only increase cell proliferation. When 
UDCA was administered as a pretreatment before DCA treatment, apoptosis was increased and 
this increase was accompanied by a constant activation of the JNK signaling pathway. Also, 
pretreatment with UDCA significantly decreased expression of the repair proteins MGMT and 
MLH1.  
One of the aims of this work was to develop an in vitro model of the in vivo 
azoxymethane (AOM)-induced colon cancer model. With the conditions tested we were able 
to induce a slight increase in cell proliferation in Caco-2 cells. This increase of cell proliferation 
could possibly be explained by the activation of the MAPK/ERK pathway, which was also 
activated with AOM treatment. Although we observed this increase in cell proliferation, we 
found no induction of O6-methylguanine lesions by our CoMeth assay or DNA damage 
observed by the comet assay. 
In the in vivo assays, the potential of an herbal tea, sage, and two isolated compounds 
found in foods from our diet, ursolic acid (UA) and EGCG, were evaluated for their 
chemopreventive effects against colorectal cancer. In the first study, sage tea was given to 
Fischer 344 rats before or after AOM treatment. Sage tea was able to reduce the number of pre-
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neoplastic lesions when given before AOM treatment, demonstrating chemopreventive 
potential. This reduction of pre-neoplastic lesions was accompanied by a reduction of the 
number of proliferating cells in colon crypts, as seen by Ki67 marker. Also, it conferred 
protection against DNA damage induced by AOM and by H2O2 ex vivo in colonocytes and 
lymphocytes. In the second study, UA and EGCG were added to the diet of healthy Fischer 
344 rats. The potential of these compounds to protect against DNA damage was assessed. We 
found that both compounds protected against endogenous DNA damage in colonocytes and 
lymphocytes. The effects of the two compounds on protection against alkylating DNA damage 
induced ex vivo was also evaluated. UA and EGCG conferred protection against this type of 
damage in colonocytes, but not in lymphocytes. 
 Finally, it has been shown that epigenetics has an important role in colon carcinogenesis, 
so we tried to develop a new, simple method to evaluate demethylating agents. We used the 
CoMeth assay developed in our group in a MMR-deficient cell line, in which one of the 
intervenients, MLH1, is epigenetically silenced by hypermethylation. Using 5-azacytidine, we 
were able to revert the hypermethylation and induce DNA damage in these cells. We further 
characterized the model, showing increase in apoptosis, and effects on reexpression of MLH1 
protein levels by western blot. We also tested a few natural compounds with the model and 
found that EGCG, which is well-known that it has demethylating ability, induced similar levels 
of DNA damage as 5-azacitidine, suggesting that the model is functional.  
 In conclusion, this work demonstrated the potential of sage tea as a chemopreventive 
agent and UA and EGCG as compounds with interest for chemopreventive strategies. The 
AOM in vitro model needs to be improved, but the adapted CoMeth assay for demethylating 
compounds is functional. Altogether, but with some additional studies, these natural 
compounds could be considered as chemopreventive agents and have possible interest in 
dietary strategies for cancer prevention. 
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Resumo 
 
A incidência do cancro colorectal está altamente relacionada com o estilo de vida das 
pessoas. A falta de exercício, hábitos de tabagismo, obesidade e a dieta são alguns fatores de 
risco. A dieta assume um papel importante na carcinogénese do cólon. Vários estudos 
demonstraram que dietas ricas em carnes vermelhas e gorduras saturadas aumentam 
significativamente a incidência desta doença. No entanto, o seu risco de aparecimento pode ser 
reduzido com uma dieta saudável, rica em frutas e vegetais. Estratégias de quimioprevenção 
do cancro do cólon baseadas na dieta, assim como no decorrer do seu tratamento, são 
necessárias para ajudar na redução da sua incidência. Com este trabalho, pretendeu-se avaliar 
a capacidade preventiva de compostos presentes na dieta no aparecimento do cancro do cólon. 
Foi, também, desenvolvido trabalho no sentido de desenvolver novos modelos que possam ser 
usados no screening de outros compostos. 
Inicialmente, o trabalho focou-se no estudo da resposta da linha celular Caco-2 à 
presença de dois ácidos biliares, o ácido deoxicólico (DCA), um promotor do cancro do cólon, 
e o ácido ursodesoxicólico (UDCA), um composto quimiopreventivo. Descobriu-se que o DCA 
induz o aumento de danos no DNA, assim como promove a apoptose na linha celular. 
Verificou-se, também, a ativação das vias de sinalização MAPK/ERK e PI3K/AKT. No caso 
do UDCA, observou-se uma ativação das mesmas vias de sinalização, no entanto, não houve 
um aumento nos danos do DNA. Desta forma, o DCA aparenta ser capaz de aumentar a 
renovação celular, visto que promove a apoptose e também a proliferação celular. O UDCA é 
apenas capaz de aumentar a proliferação celular. Quando o UDCA foi administrado como pré-
tratamento ao tratamento com DCA, verificou-se um aumento da apoptose, o qual foi 
acompanhado de uma ativação constante da via de sinalização JNK. O pré-tratamento com 
UDCA foi, também, responsável por uma redução significativa da expressão das enzimas de 
reparação MGMT e MLH1. 
Com este trabalho, também se pretendeu desenvolver um modelo in vitro do modelo in 
vivo de indução do cancro do cólon com azoximetano (AOM). As condições usadas permitiram 
induzir um ligeiro aumento da proliferação celular. Este aumento da proliferação pode ser 
explicado pela ativação da via de sinalização MAPK/ERK, a qual também foi ativada pelo 
tratamento com AOM. Apesar do aumento observado da proliferação celular, não se 
identificaram danos do tipo O6-metilguanina, recorrendo ao método CoMeth, nem danos no 
DNA, observados por comet assay. 
Resumo 
viii 
 
Nos estudos in vivo, avaliou-se o potencial quimiopreventivo do chá de Sálvia e de dois 
compostos isolados presentes na dieta, o ácido ursólico (UA) e o (-)-epigalocatequina-3-galato 
(EGCG), contra o cancro colorectal,. No primeiro estudo, ratos Fischer 344 consumiram chá 
de Sálvia antes ou após o tratamento com AOM. O chá foi capaz de reduzir o número de lesões 
pré-neoplásicas quando administrado antes do tratamento com AOM, demonstrando o seu 
potencial quimiopreventivo. Essa redução de lesões pré-neoplásicas foi acompanhada duma 
redução do número de células proliferativas nas criptas do cólon, observado com o marcador 
Ki67. Foi, também, observada proteção do DNA contra danos induzidos por AOM e por 
H2O2 em ensaios ex vivo com colonócitos e linfócitos. No segundo estudo, incluiu-se UA e 
EGCG na dieta de ratos Fischer 344 saudáveis, avaliando-se o seu potencial protetor contra 
danos de DNA. Os resultados mostraram que, em colonócitos e linfócitos, ambos os compostos 
conferem proteção contra danos endógenos do DNA. O seu potencial contra danos alquilantes 
induzidos no DNA foi, também, avaliado em ensaios ex vivo. Nos colonócitos, foi possível 
observar proteção conferida pelo UA e pelo EGCG contra este tipo de danos, ao contrário do 
observado no caso dos linfócitos. 
Por fim, uma vez que a epigenética assume um papel importante na carcinogénese do 
cólon, criou-se um método novo, e simples, para avaliação de agentes desmetilantes. O método 
CoMeth, desenvolvido do nosso grupo de investigação, foi usado numa linha celular deficiente 
no sistema de Mismatch repair (MMR), na qual o gene MLH1 se encontra epigeneticamente 
silenciado por hipermetilação. Usado a 5-azacitidina, foi possível reverter a hipermetilação e 
induzir danos no DNA nestas células. Foi, também, observado um aumento da apoptose e, pela 
técnica de western blot, percebeu-se que existe reexpressão da proteína MLH1. Vários 
compostos naturais foram usados para validar o método e, entre eles, o EGCG, que é conhecido 
pela sua capacidade de desmetilação, induziu níveis de danos no DNA semelhantes àqueles 
observados com a 5-azacitidina, validando a funcionalidade do método. 
Assim, este trabalho comprovou não só o potencial quimiopreventivo do chá de Sálvia 
mas também o potencial do UA e do EGCG como parte integrante duma estratégia 
quimiopreventiva. O método CoMeth provou ser funcional na avaliação de potenciais agentes 
desmetilantes, contudo, o modelo in vitro do AOM precisa de ser melhorado. No seu conjunto, 
apesar de ser necessário completar os estudos já realizados, os compostos naturais estudados 
podem ser considerados agentes quimiopreventivos, conferindo-lhes o potencial para aplicação 
em estratégicas de prevenção de cancro baseadas na dieta.
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1 – Colorectal Cancer 
 
1.1 – Incidence and general concepts 
 
Colorectal cancer (CRC) is a common malignancy and significant cause of 
mortality in Western societies. Worldwide, CRC is the third most common cancer in men 
and second in women (Figure 1a), while being the fourth most common cause of death 
from cancer. In Portugal, it is the second most common cancer in men and in women, 
behind prostate and breast cancer, respectively (Figure 1b) [Ferlay, J., et al., 2010].  
 
 
Figure 1 – Representation of the incidence of different cancers in men and in women, in the world 
(A) and specifically in Portugal (B). Adapted from [Ferlay, J., et al., 2010]. 
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The carcinogenic process is multi-step and usually several years are needed for a 
tumor to reach an invasive stage. This process can be divided into three distinct phases: 
initiation, phase where genetic alterations occur and the irreversible changes confer an 
intrinsic capacity to proliferate uncontrollably; promotion, phase when the initiated cells 
continue to divide giving rise to a detectable neoplasm; and progression, where the 
neoplasm acquires increased invasiveness and metastatic potential [Frank, S.A., 2007; 
Grady, W.M., et al., 2008]. 
CRC usually develops through the inheritance of a genetic defect or induction of 
DNA damage. Afterwards, the accumulation of further genetic and epigenetic alterations 
transforms normal colon cells and gives them growth advantage over their neighboring 
cells. Other factors that have been implicated in the onset of the disease are diet, obesity, 
lack of physical activity, smoking habits and exposure to chemical or biological 
carcinogens. The evolution of normal tissue to adenocarcinoma usually follows a known 
progression of histological changes and simultaneous genetic and epigenetic 
modifications [Frank, S.A., 2007].  
The first alterations that appear during the carcinogenic process usually involve 
gatekeeper or caretaker genes. A gatekeeper gene is a gene that controls the initiation of 
a neoplasm, such as the adenomatous polyposis coli (APC) tumor suppressor gene, while 
a caretaker gene may also be one controlling the rate of accumulation of genetic 
alterations, such as the DNA mismatch repair (MMR) genes [Fearon, E.R., 2011; Frank, 
S.A., 2007; Redston, M., 2001]. With these alterations, progressive defects in important 
cellular pathways are activated, inducing cell proliferation, preventing apoptosis and 
senescence, and predisposing to failure to recognize and repair DNA damage [Walker, J., 
et al., 2001]. Some altered pathways in colorectal cancer are the mitogen-activated protein 
kinase pathway and WNT signaling pathway, which will be described in more detail in 
the following segment.  
 
1.2 – Signaling pathways  
 
 1.2.1 – WNT signaling 
The WNT signaling pathway is important for embryonic development, but also 
regulates homeostasis in self-renewing tissues, such as the colonic epithelial. At the center 
of this pathway is the highly regulated β-catenin protein, encoded by the CTNNB1 gene. 
β-catenin is found in three different sites in the cell: first, at cellular adherent junctions, 
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interacting with E-cadherin; in the cytosol; and finally in the nucleus. In normal cells, the 
absence of WNT signals favors the proteasomal degradation of cytoplasmic β-catenin and 
this degradation is initiated by a multi-protein “destruction” complex (Figure 2). This 
complex is formed by adenomatous polyposis coli (APC) and AXIN, which are important 
for binding of -catenin to the complex, and glycogen synthase kinase 3 β (GSK3β and 
casein kinase 1 (CK1), which are responsible for the phosphorylation of the protein. The 
“destruction” complex phosphorylates the N-terminus of the protein, targeting it for 
proteasomal degradation. This regulation maintains the cytosolic levels of the protein 
relatively low. Binding of Wnt signals to specific receptors in the cell membrane, frizzled 
(Fzd) and low-density lipoprotein receptor-related protein (LRP), inhibit -catenin 
phosphorylation, enabling this protein to accumulate in the cytosol and translocate to the 
nucleus. In this cellular compartment, -catenin interacts with a family of transcription 
factors, the T-cell factor/lymphoid enhancer factor (TCF/LEF), to activate target genes, 
mostly genes involved in differentiation, proliferation, migration, and adhesion [Burgess, 
A.W., et al., 2011; White, B.D., et al., 2012]. 
Aberrant WNT signaling is widely implicated in diseases, such as cancer. In CRC, 
a high number of tumors have an alteration in a protein of the WNT pathway, the most 
common being APC or CTNNB1, in which most of these tumors show β-catenin 
accumulation in the nucleus. Although mutations in these genes result in activation of the 
pathway and accumulation of β-catenin in the nucleus, it seems that they are not 
functionally equivalent. It seems that APC and CTNNB1 mutations are mutually exclusive, 
so tumors either have one or the other. CTNNB1 mutations have been associated with 
small colorectal adenomas and also hereditary nonpolyposis colorectal cancer (HNPCC), 
while APC mutations are associated with the familial adenomatous polyposis (FAP). But 
even between cells within the same tumor, there are differences in WNT signaling. CRC 
tumors with activating WNT signaling mutations show inconsistent levels of signaling, 
suggesting other mechanisms of pathway regulation, such as epigenetic silencing or 
pathway crosstalk. Also, APC mutations have been found to cause significant alterations 
at the cell membrane, influencing cell adhesion and migration. These mutations activate 
the pathway at different levels, promoting tumor progression by different mechanisms, 
ultimately prompting different types of tumors [Burgess, A.W., et al., 2011; White, B.D., 
et al., 2012; Zeller, E., et al., 2013].  
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Figure 2 – Schematic figure depicting the Wnt/β-catenin pathway. (A) In the absence of Wnt signal, β-
catenin is phosphorylated by a destruction complex containing AXIN, APC, GSK3, and CK1 proteins. N-
terminal phosphorylated β-catenin is targeted proteasomal degradation. (B) Wnt ligands initiate signaling 
through FZD and LRP receptor, activating and recruiting DVL (Disheveled) and Axin to the membrane, 
thereby disrupting the destruction complex. Higher cytosolic levels of β-catenin result in its translocation 
into the nucleus, where it binds TCF/LEF transcription factors, activating WNT target genes. Adapted from 
[White, B.D., et al., 2012].  
 
1.2.2 – Extracellular signal-regulated kinase (MAPK/ERK) pathway 
 The mitogen-activated protein kinase (MAPK) pathway is a highly conserved 
signaling pathway that controls important cellular processes that include cell proliferation 
and differentiation. Three distinct groups of regulated MAPK cascades are known in 
humans that lead to altered gene expression. One of them is the extracellular signal-
regulated kinase (MAPK/ERK) pathway. Activation of this pathway starts with an 
extracellular stimulus, such as a ligand binding to its respective receptor, for example 
epidermal growth factor (EGF) and EGF receptor (EGFR), which becomes dimerised and 
phosphorylated (Figure 3). A complex of proteins, that include growth factor receptor-
bound protein 2 (GRB2) and son of sevenless homologue (SOS), can now bind to the 
phosphorylated domain of the receptor. Simultaneously, a protein with guanine exchange 
factor (GEF) activity, which is also in the protein complex, binds to RAS protein. This 
GEF protein displaces guanosine diphosphate (GDP) molecules from RAS and allows 
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guanosine triphosphate (GTP) molecules to bind, thus activating RAS. Active RAS binds 
to RAF, recruiting it to the membrane and activating it. After activation, RAF proteins 
phosphorylate and activate MEK, which in turn, phosphorylate and activate ERK1/2. 
ERK1/2 protein then either phosphorylates target substrates in the cytosol or is 
translocated to the nucleus where it activates a range of transcription factors, for example, 
Jun and Fos, and these, in turn, bind to the AP-1 DNA domain promoting transcription of 
genes involved in regulation of cell proliferation. In normal cells, regulation of the 
pathway is done by RAS-GTPase activating proteins (GAP), which hydrolyze GTP to 
GDP, inactivating RAS protein, and blocking the pathway [Meister, M., et al., 2013; 
Zenonos, K., et al., 2013]. 
 
 
Figure 3 – Schematic representation of the MAPK/ERK cascade. Activation of the pathway by binding of 
a growth factor to a receptor results in recruitment of GRB2 and SOS, which then interacts with and 
activates RAS. This results in phosphorylation of Raf and, thereby, the initiation of sequential 
phosphorylation steps of MEK and ERK. Activated ERK can phosphorylate either cytosolic or nuclear 
substrates. Adapted from [Meister, M., et al., 2013]. 
 
Deregulation of the MAPK/ERK pathway is common in carcinogenesis. The RAS 
family of proteins was the first oncogene discovered. There are several subtypes of RAS 
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protein, such as HRAS, NRAS, ERAS, MRAS and KRAS, but the most common gene 
mutated in colorectal cancer is KRAS, followed by NRAS. Among the most frequent 
alterations, we find RAS and RAF mutations. About half of all CRC cases present a KRAS 
mutation, while NRAS mutation is found in only fewer cases of CRC. Mutations in the 
KRAS gene are usually found in specific positions at codons 12, 13, and 61, stabilizing 
the protein into a constant active state. These mutations usually lead to conformational 
changes in the protein, interfering with RAS-GAP activity and maintaining RAS 
constantly active, promoting tumorigenic properties by constant MAPK pathway 
activation. BRAF mutations appear in about 5% to 10% of all CRC cases. There are three 
isoforms of the RAF protein, C-RAF, also RAF-1, A-RAF and B-RAF. Mutations in 
BRAF lead to increased kinase activity, also promoting MAPK pathway activation. The 
most common mutation of the BRAF gene is the V600E mutation, a transversion of a 
thymine by an adenine, causing a substitution of amino acids. Both types of mutations 
lead to deregulation of the MAPK/ERK pathway and increased cell proliferation and 
tumor growth [Arends, M.J., 2013; Nandan, M.O., et al., 2011; Zenonos, K., et al., 2013]. 
 
1.2.3 – c-Jun amino N-terminal kinase (JNK) pathway 
 Another pathway of the MAPK is the c-Jun amino N-terminal kinase (JNK) 
pathway. The JNK pathway, also known as the stress-activated protein kinase (SAPK), is 
mainly activated in response to stress signals. In humans, three JNK genes can be found, 
JNK1 and JNK2, which are ubiquitously expressed, and JNK3, which is mainly expressed 
in the brain, cardiac smooth muscle and testes. Being part of the MAPK cascade, it is also 
a cascade with triple kinase (Figure 4). The signaling cascade starts with a stress stimulus. 
Various stresses strongly activate JNK pathway, such as cytokines, irradiation, cytotoxic 
drugs, DNA damaging agents, and reactive oxygen species (ROS). These stress stimuli 
activate various MAP3 kinases, such as MEKK1, mixed lineage kinase 2 (MLK2), MLK3, 
transforming growth factor-β-activated kinase 1 (TAK1) and apoptosis signal-regulating 
kinase-1 (ASK1). These, in turn, activate by phosphorylation MKK-3, MKK-4, MKK-6 
and MKK-7, and these ultimately activate JNK1 and JNK2. JNK can stay in the cytosol 
or translocate to the nucleus, so not only does JNK regulate transcription factors in the 
nucleus, such as c-Fos, c-Jun, ATF-2, AP-1, p53, and ELK1, but also modulates 
cytoskeletal and mitochondrial proteins, example of the latter being Bcl-2 and Bcl-xl 
[Sehgal, V., et al., 2013; Sui, X., et al., 2014].  
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Figure 4 – Schematic representation of the JNK pathway. Activation of the pathway by stress stimulus. 
These stress stimuli activate various MAP3 kinases, such as MEKK1, MLK3, TAK1, and ASK1. These, in 
turn, phosphorylate MKK4 or MKK7. JNK1 and JNK2 are phosphorylated by these last kinases, and 
activate various proteins in the cytosol or in the nucleus.  
 
 JNK pathway has been associated with a plethora of cellular processes, such as 
apoptosis, autophagy, metabolism, cell proliferation, and DNA repair. Whether JNK 
activation leads to cell proliferation or apoptosis depends on the type of cell involved and 
the stimuli received. Apoptosis is regulated by JNK through two different mechanisms. 
First, promotion of c-Jun and ATF-2 phosphorylation results in AP-1 activation and 
expression of Fas/FasL signaling pathway-related proteins. This Fas/FasL binding can 
mediate caspase 8 and caspase 3 activation, which will lead to apoptosis. Second, in the 
cytosol, JNK phosphorylates Bcl-2/Bcl-xL, which are anti-apoptotic proteins, changing 
the mitochondrial membrane potential and inducing caspase 9 and caspase 3 activation, 
also leading to apoptosis. So, looking at the classification of signaling pathways that 
initiate apoptosis as extrinsic or intrinsic, it is safe to say that JNK activation has an 
important role in both pathways. [Dhanasekaran, D.N., et al., 2008; Sui, X., et al., 2014].  
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1.2.4 – Phosphatidylinositol-3-kinase (PI3K)/AKT pathway 
 The phosphatidylinositol-3-kinase (PI3K)/AKT pathway has an important role in 
regulating cell survival in response to cellular stress. It is activated by growth factors that 
bind to receptor tyrosine kinases (RTKs), as in the MAPK pathways (Figure 5). After 
binding to the receptor, PI3K protein is recruited to the receptor, stimulating the 
conversion of phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-
3,4,5-triphosphate (PIP3). This conversion can be reversely regulated by the protein 
PTEN, converting PIP3 into PIP2. PI3K protein has two subunits: p110, which has 
catalytic activity, and p85, which is the regulatory subunit. PIP3 provides a docking area 
for proteins with pleckstrin homology (PH) domains, such as protein serine/threonine 
kinase-3’-phophoinositide-dependent kinase 1 (PDK1) and AKT/protein kinase B (PKB). 
AKT/PKB regulates several cell processes after activation [Porta, C., et al., 2014; Zhang, 
L., et al., 2013]. 
In normal cells and after appropriate stimuli, AKT/PKB protein can inhibit 
apoptosis by inactivating pro-apoptotic factors, such as BAD and caspase-9. It also 
phosphorylates GSK3β at Serine 9, which blocks the protein activity. As referred before, 
GSK3β is involved in β-catenin regulation and degradation. With GSK3β inhibited, there 
is an accumulation of β-catenin in the nucleus, inducing cell proliferation. AKT may also 
promote survival by phosphorylating HDM2, and this, in turn, promotes translocation to 
the nucleus, where it triggers p53 degradation [Manning, B.D., et al., 2007; Zhang, L., et 
al., 2013]. Cancer cells may present mutations in components of this pathway, leading to 
increased proliferation and decreased apoptosis. PI3KCA mutations have been found in 
some colorectal tumors. These mutations are mostly found in the catalytic subunit of the 
protein, affecting PIP2 to PIP3 conversion. It has been shown that, unlike other mutations 
that are mutually exclusive, PI3KCA mutations are significantly associated with KRAS 
mutations and loss of expression of a DNA repair enzyme O6-methylguanine-DNA 
methyltransferase (MGMT). PTEN is a phosphatase that acts as a tumor suppressor by 
suppressing cell proliferation by inhibiting AKT activation. PTEN mutations are 
frequently found in advanced stages of carcinogenesis. Mutations in this gene prevent the 
negative regulatory control of this protein, allowing for constant cell growth [Cathomas, 
G., 2014; Porta, C., et al., 2014].  
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Figure 5 – Schematic representation of the PI3K/AKT pathways. Upon RTK activation, PI3K catalyzes 
the conversion of PIP2 to PIP3. PIP3 allows recruitment to membrane of AKT, where it gets phosphorylated 
and induces proliferation and inhibits apoptosis. Adapted from [Zhang, L., et al., 2013]. 
 
1.3 – DNA repair systems 
 
Genomic instability has been recognized as a trait of the majority of solid tumors. 
There are many forms of genomic instability. One of the most common forms found in 
cancer is chromosomal instability (CIN). CIN is characterized by a high rate of changes 
in chromosome structure and number over time. It seems that cancer cells acquire new 
chromosomal abnormalities over time. Another type of genomic instability found in 
cancer cells is microsatellite instability (MSI). This type of abnormality is characterized 
by the increase or decrease of the number of oligonucleotide repeats present in a 
microsatellite sequence. Increased frequencies of base-pair mutations can also contribute 
to genomic instability in cancer cells. 
These genomic alterations and mutations can alter the cell’s behavior, in the 
initiation and/or progression process, and how the tumor will respond to therapy in cancer 
treatment. Due to the destructive effects of genomic instability, and the fact that the 
integrity of DNA is constantly being challenged, cells have DNA repair systems to detect 
and correct the lesions before being passed to daughter cells by division [Lord, C.J., et 
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al., 2012; Negrini, S., et al., 2010]. These repair systems recognize and repair specific 
and different types of damage [Ramos, A.A., et al., 2011]. In the next section, we will 
describe in more detail a few of these repair systems.  
 
1.3.1 – The DNA Mismatch Repair system 
The mismatch repair (MMR) system comprises a number of proteins that 
recognize and directly repair nucleotide mismatches, mainly base-base mismatches and 
insertion/deletion loops. The target DNA sequences of this repair system are residual 
errors that have escaped the normal proofreading function of the replication system. These 
mispairs, if not corrected, may cause nucleotide transitions or transversions, and 
consequently cause point mutations. These point mutations can appear in genes that 
regulate cell growth and accumulation of these in cells may promote neoplastic growth 
[Lord, C.J., et al., 2012; Marra, G., et al., 2005; Ramos, A.A., et al., 2011]. 
In human cells, at least six MMR proteins are needed for correct repair (Figure 6). 
MSH2 protein forms a heterodimer with MSH6 or MSH3 for mismatch recognition. The 
binding depends on the type of mispair found, where MSH2-MSH6 (hMutS complex) 
detects base-base mispairs and small insertion-deletion loops while MSH2-MSH3 
(hMutS complex) only detects larger loops. After recognition by the first complex, 
another heterodimer, hMutL composed of MLH1 and PMS2, coordinates the 
interaction between the recognition complexes and the other proteins necessary for repair, 
such as PCNA, DNA polymerases and single-stranded DNA–binding protein. All these 
interactions lead to the excision of the mispair or loop and resynthesis of DNA by DNA 
polymerase [Lord, C.J., et al., 2012; Marra, G., et al., 2005; Ramos, A.A., et al., 2011]. 
DNA repair pathways are important for the normal cell correction, but also for cancer 
treatment. Defects in the mismatch repair system, specifically mutation or epigenetic 
modifications of MLH1 or MSH2, have been observed in some cases of CRC. This is the 
case of hereditary non-polyposis colorectal cancer, which is associated with loss-of-
function mutations of these mismatch repair genes.  
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Figure 6 – Schematic representation of the mismatch repair system recognition. A hMutS complex 
identifies the lesion and recruits the MutL complex to the location. This complex coordinates the interaction 
between the recognition complexes and the other proteins necessary for repair, such as PCNA, DNA 
polymerases and single-stranded DNA–binding protein.  
 
1.3.2 – Direct damage reversal repair 
We are constantly in contact with mutagens from our environment, as well as 
endogenous metabolic products, both generating reactive electrophilic species which 
alkylate DNA. The O6-methylguanine adduct (O6-MeG) is a crucial lesion due to its 
mutagenic and toxic potential. It allows DNA replication to continue but causing a 
mispair with thymine instead of cytosine and, during the replication process, causing 
GCAT transitions. This lesion is very stable if not repaired by MGMT. MGMT repairs 
O6-alkylation adducts, by direct damage reversal, in a one-step alkyl transfer reaction, 
transferring the alkyl group from the oxygen in the guanine nucleotide in the DNA to a 
cysteine residue of the protein, a process that inactivates MGMT [Kaina, B., et al., 2007; 
Ramos, A.A., et al., 2011]. If MGMT fails to remove the alkyl group, the mispair is 
recognized by the MMR pathway, removing the thymine and inserting a gap. In the next 
round of replication, O6-MeG mispairs again, and the thymine is removed once more. 
This loop continues, if O6-MeG remains in one of the templates, creating a “futile repair 
loop”, eventually resulting in toxic double-strand breaks, leading to apoptosis or 
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chromosomal aberrations (Figure 7). It is known that O6-MeG is a common cause of 
mutations responsible for carcinogenesis initiation, especially activation of oncogenes 
and inactivation of tumor suppressor genes. MGMT is also frequently silenced in sporadic 
colon tumors by promoter hypermethylation, demonstrating the important role of this 
protein in cancer prevention [Kaina, B., et al., 2007; Ramos, A.A., et al., 2011].  
 
 
Figure 7 – MGMT repair of O6-MeG lesion. MGMT repairs the lesion by direct damage reversal 
inactivating the protein. If the lesion is not repaired, the mispair is recognized by the MMR pathway, 
removing it and inserting a gap. MMR keeps inserting a gap in every replication cycle, creating a “futile 
repair loop”, which ultimately leads to apoptosis. If MMR is not functional, then the mispair continues in 
the strand and, in the next replication, thymine is paired with an adenine, resulting in a point mutation. 
Adapted from [Allan, J.M., et al., 2005]. 
 
1.4 – Epigenetics and cancer 
 
In the past decade, it has been found that carcinogenesis does not arise by just 
genetic alterations in the DNA sequence, but also by alterations in gene expression that 
do not involve changes in the DNA sequence. This regulation is termed epigenetic 
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regulation and they are reversible, being transmitted during mitosis or meiosis. Epigenetic 
DNA modifications are an alternative pathway for colorectal carcinogenesis, affecting 
gene function even in the absence of mutations. Most colorectal tumors have epigenetic 
modifications that coexist with classical genetic alterations, such as P53, -catenin and 
KRAS mutations. Epigenetic alterations found to contribute to malignant phenotypes are 
5’ cytosine methylation of CpG island and histone modifications [Goel, A., et al., 2012]. 
 
1.4.1 – Epigenetic silencing by DNA methylation 
Gene expression is regulated by interactions between transcription factors and the 
start codon (ATG) and the DNA sequences immediately before or after the start sequence. 
Cytosine methylation is the most well-known epigenetic change. The promoter regions 
are rich in C-G sequences, termed CpG islands, around 60% of all the human promoters, 
and in normal cells, methylation is usually found in CpG-poor regions and CpG-rich 
regions are normally protected from this type of modification [Kulis, M., et al., 2010]. 
DNA methylation, controlled by DNA methyltransferases (DNMT), is necessary during 
development, but aberrant DNA methylation is known to be an important event in cancer 
development. Occasionally, the first exon and promoter regions of “housekeeping” genes 
or tissue-specific genes have unmethylated CpG islands. Fully methylated CpG islands 
are important in promoter regions of silenced alleles for selected imprinted autosomal 
genes and multiple silenced genes on the inactivated X-chromosome of females [Baylin, 
S.B., et al., 2000; Goel, A., et al., 2012; Kondo, Y., et al., 2004].  
As referred previously, the methylation of cytosines is mediated by a class of 
enzymes termed DNMT. Five members of this family have been identified until now in 
mammals: DNMT1, DNMT3a, DNMT3b, DNMT2 and DNMT3L, although only the first 
three have been found to participate in the assembly of the methylation pattern. These 
enzymes catalyze the addition of a methyl group to the 5’ carbon of a cytosine, forming 
5-methyl-cytosine. DNMT1 is the most abundant of the DNMT in somatic cells and 
interacts with the proliferating cell nuclear antigen (PCNA). DNMT1 is thought to be 
responsible for the copying of the methylation pattern after DNA replication, being 
referred as the “maintenance” methyltransferase. Both DNMT3a and DNMT3b are 
required for the de novo methylation that occurs in the genome following embryonic 
implantation, being referred as the “de novo” methyltransferases [Baylin, S.B., et al., 
2000].  
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DNMT1 is the major enzyme for maintenance of the methylation status of DNA 
during replication, but is also important for appropriate histone H3 modification, crucial 
for chromatin domain organization. DNMT1 is located at the replication fork and 
methylates the newly synthesized, hemimethylated DNA strand to maintain precisely the 
original DNA methylation pattern. DNMT1 recruits chromatin-modifying enzymes, such 
as HDAC1, HDAC2 and histone methyltransferase, and is important for the initiation of 
chromatin remodeling and, consequently, regulation of gene expression. The N-terminal 
domain of DNMT1 is essential to discriminate between hemimethylated and 
unmethylated DNA strands, having preference for the first one, decreasing the “de novo” 
methylation activity of this enzyme [Turek-Plewa, J., et al., 2005]. Loss of DNMT1 
function results in embryonic lethality in mice, demonstrating the importance of this 
protein for normal cell function [Kulis, M., et al., 2010].  
DNMT3a and DNMT3b methylate CpG dinucleotides and are responsible for the 
“de novo” methylation of DNA, especially during embryogenesis and their levels remain 
low in adult somatic tissues. Unlike DNMT1, these methyltransferases methylate without 
preference for hemimethylated DNA. DNMT3a expression is ubiquitous, but DNMT3b 
is expressed at low levels in most tissues and is intensely increased in tumor cell lines. 
These two enzymes can interact with DNMT1 and activate HDAC1, repressing gene 
transcription which indicates that DNMT3a and 3b may be involved in chromatin 
remodeling associated with gene transcription regulation. This may indicate that 
DNMT3b is important for tumorigenesis [Turek-Plewa, J., et al., 2005]. Inactivation of 
these proteins leads to embryonic lethality, DNMT3b, or death shortly after birth, 
DNMT3a, in knockout mice. This could indicate that DNMT3b is important in the early 
stages of development, while DNMT3a is relevant in the later stages or after birth [Kulis, 
M., et al., 2010]. 
The methylation status of regulatory DNA sequences is correlated with the 
transcriptional activity of genes. The presence of methylated CpG dinucleotides in the 
promoter region or first exon of the gene may have a direct or indirect effect on 
transcription. Methylation affects the promoter region and the start site of the gene, 
altering the configuration of the DNA strand, interfering with binding of transcription 
factors, silencing gene expression. This way, transcription factors do not bind correctly 
to the promoter region, preventing transcription. Indirectly, specific DNA-binding 
proteins will bind to the methylated CpG dinucleotides, which then block the interaction 
of the transcription factors with the DNA. It is considered that DNA methylation is the 
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initial step for establishing the inactive chromatin state. These proteins include m5CpG-
binding domain proteins (MBD) and m5CpG-binding proteins (MeCPs) which are able to 
form complexes with histone deacetylases (HDAC) and ATP-dependent chromatin 
remodeling proteins. These proteins, in turn, are involved in the stabilization of the 
heterochromatin (transcriptionally inactive chromatin) structure, and gene silencing is 
achieved. These modifications are stably passed to the daughter cells, maintaining the 
methylation pattern in the next generation [Baylin, S.B., et al., 2000; Goel, A., et al., 
2012; Kulis, M., et al., 2010].  
 
1.4.2 – Epigenetic silencing by histone modifications 
Along with DNA methylation-induced transcriptional gene expression control, 
posttranslational covalent modifications of histones constitute another epigenetic 
mechanism. Histone modifications in the N-terminal tail control chromatin structure, and 
therefore gene expression. In the nucleus of eukaryotic cells, DNA is tightly condensed 
into chromatin, functioning as a scaffold in the regulation nuclear processes, such as 
transcription, DNA replication and repair, apoptosis and mitosis. The status of chromatin 
structures affects the ability of transcriptional regulatory proteins and RNA polymerase 
to access specific promoter regions, and consequently activate gene transcription. So, 
unmethylated chromatin is typically active while methylated chromatin is inactive 
[Baylin, S.B., et al., 2000; Zheng, Y.G., et al., 2008]. 
As referred before, histone modifications is another mechanism of epigenetic 
silencing of genes. Genomic DNA is folded by both histone, that are organized in 
cylindrical structures and constitute the histone core, and non-histone proteins, forming 
nucleosomes and a more structured form, referred to as chromatin. This dynamic 
packaging of the DNA is important to switch between on and off states of transcription, 
controlling gene activation and silencing. It is known that histone tail domains can be 
modified by a variety of processes, such as acetylation, phosphorylation and methylation. 
Histones modifications are governed by two factors: the type of modification and the 
amino acid involved in the modification. Histone methylation and 
acetylation/deacetylation are epigenetic modifications that are reversible and responsible 
for the activation or silencing of transcription, respectively. Histone modifications usually 
occur at 4 histones, H2A, H2B, H3, and H4. Histone acetyltransferases (HAT) and HDAC 
maintain the level of acetylation of the chromatin histones, balancing the 
euchromatin/heterochromatin structure. It is known that hypoacetylation of histones is 
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typically involved in gene silencing, while hyperacetylation activates gene expression. 
HATs add acetyl groups to lysine residues in histone tails, neutralizing their positive 
charges and relaxing the chromatin structure. HDACs interact with transcriptional 
activators and co-activators, reversing the action of HAT, condensing chromatin and not 
allowing transcription to occur. Methylation/demethylation is also controlled by enzymes 
termed histone methyltransferases and histone demethylases, respectively [Fang, J.Y., et 
al., 2004; Goel, A., et al., 2012]. 
 
1.4.3 – Epigenetic silencing and cancer 
It has been found that tumors are overall hypomethylated, with the exception of 
specific hypermethylated genes. This hypomethylation contributes to genomic instability 
and activation of silenced oncogenes. Promoter hypermethylation is accepted as a 
mechanism for gene silencing, especially of tumor suppressor genes. This was first 
demonstrated in studies of retinoblastoma patients in which the promoter region of 
retinoblastoma tumor suppressor gene (RB1) was hypermethylated. Gene inactivation 
resulting from DNA promoter hypermethylation and histone deacetylation is a frequent 
epigenetic event in malignant transformation. This phenotype in which tumor suppressor 
genes are methylated and carcinogenesis occurs through silencing is termed “CpG island 
methylator phenotype” or CIMP. Many genes have been found to be hypermethylated in 
CRC tissue, such as DNA repair genes, hMLH1 and MGMT, and cell cycle regulators, 
p16 and p15, and substantial degrees of hypermethylation have been found already in 
early colon cancer lesions, aberrant crypt foci (ACF) [Goel, A., et al., 2012; Kulis, M., et 
al., 2010]. It is possible to classify tumors as non-CIMP, CIMP-low and CIMP-high 
according to the proportion of promoters that surpass a certain degree of DNA 
methylation. CIMP-high appears in around 15% of CRC cases and is almost always 
present in tumors with MLH1 silencing [Goel, A., et al., 2012]. The death-associated 
protein kinase or DAPK is a protein involved in apoptotic and autophagic cell death, 
tumor and metastasis suppression. This protein induces cell death when overexpressed in 
cells. It has been found to possess a hypermethylated promoter in more than 20 types of 
human cancers including lymphomas, lung, breast, colon, prostate and brain. This fact 
further implies the tumor suppressor activity of this protein [Gozuacik, D., et al., 2006]. 
As referred previously, hyperacetylation of histones opens chromatin, a process 
necessary for transcriptional activation. It has been shown that transcriptionally inactive 
gene promoters are characterized by trimethylation of histone H3 lysine 9 and 27, 
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H3K9me3 and H3K27me3, respectively. Transcriptionally active modifications found are 
dimethylation and trimethylation of histone H3 lysine (H3K4me2/me3) and acetylation 
of H3/H4 (H3K9Ac and H4K9Ac). So, HDAC inhibitors, such as sodium butyrate (a 
short chain fatty acid), have been investigated as possible candidates for cancer treatment 
because of the effects on genes regulating proliferation [Fang, J.Y., et al., 2004; Spurling, 
C.C., et al., 2008; Zheng, Y.G., et al., 2008]. 
   
1.5 – Molecular pathways to CRC 
 
Colorectal cancer is a major health problem, as it is one of the most common types 
of cancer worldwide. With the scientific advances, CRC has been shown to be a very 
heterogeneous disease. Nowadays, the molecular and genetic features of the tumors have 
an important role in the prognosis and treatment of the disease. The majority of CRC 
cases arise as sporadic carcinomas and develop through the classical adenoma-carcinoma 
sequence (Figure 8). Common APC changes which lead to a truncated protein, affecting 
-catenin degradation by the proteasome, are considered to be initiating events. As 
mentioned above, destabilization of the complex allows -catenin to be translocated to 
the nucleus and activate transcription of key players in the regulation of proliferation and 
apoptosis [Arends, M.J., 2013; Fearon, E.R., 2011]. In a study conducted with human 
samples of CRC, WNT signalling pathway was altered in 93% of all the cases studied, 
either by inactivation of APC, activating mutation of -catenin, and alterations in other 
pathway intervenients [Network, T.C.G.A., 2012]. APC has also been found to be 
involved in exporting -catenin from the nucleus, reducing transcription of -catenin 
target genes. KRAS mutations are thought to be important for adenoma progression. The 
same study with human samples found that 55% of non-hypermutated tumors had 
activating alterations affecting KRAS, NRAS or BRAF [Network, T.C.G.A., 2012]. The 
tumor suppressor p53 protein is the “guardian of the genome” due to its pivotal role in 
responding to DNA damage-induced stress by interrupting the cell cycle for DNA repair 
or induction of apoptosis. Mutations in this gene are found in more than 60% of CRC, 
usually appearing at later stages of the adenoma-carcinoma transformation [Arends, M.J., 
2013].  
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Figure 8 – The colorectal adenoma-carcinoma sequence. The adenoma-carcinoma sequence shows the 
transitions from normal through the earliest stage of aberrant crypt foci to adenomas and ultimately 
carcinomas. Key molecular alterations are highlighted to distinguish sporadic, FAP and HNPCC. Adapted 
from [Fearon, E.R., 2011; Frank, S.A., 2007].  
 
Less than half of CRC cases can be classified as hereditary colon cancer. Familial 
adenomatous polyposis coli syndrome (FAP) is a type of hereditary colon cancer that 
starts with an inherited mutated APC gene. This alteration causes the development of 
hundreds of adenomatous polyps in the colon and increases the risk of CRC to nearly 
100%. FAP patients inherit an APC mutation in one allele and are wild-type in the other 
allele, acquiring the second APC alteration, which can be a mutation or promoter 
methylation. All the cells of a FAP patient have the initial APC mutation and the second 
alteration happens in a number of colorectal cells, leading to hundreds of adenomas 
[Arends, M.J., 2013; Fearon, E.R., 2011; van Wezel, T., et al., 2012]. In hereditary 
nonpolyposis colorectal cancer (HNPCC) syndrome, also known as Lynch syndrome 
(LS), there is an inherited alteration, mutation or epigenetic silencing, in a MMR gene in 
one allele, in which the most commonly inherited mutant genes are MLH1 and MSH2. 
After the inactivation of the same gene in the second allele, the cell’s MMR system 
becomes faulty, increasing the rate of mutation due to the inability to repair DNA damage. 
When the mutations occur at nucleotide repeats, termed microsatellites, microsatellite 
instability arises, and this is also a common characteristic of LS. These patients develop 
a smaller number of polyps, but it is believed that these progress at a faster rate to 
carcinoma [Arends, M.J., 2013; Banno, K., et al., 2012; Fearon, E.R., 2011]. 
Apart from the conventional adenoma-carcinoma, the serrated neoplasia pathway 
can be responsible for around 30% of CRC cases. This pathway involves the transition of 
hyperplastic polyps, which are found in patients with hyperplastic polyposis syndrome, 
to serrated adenomas, and then further to invasive adenocarcinomas. In this pathway, two 
molecular features, MAPK pathway activation and CIMP, in which the MAPK pathway 
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activation can appear due to BRAF or KRAS mutation. There are three major categories 
of serrated polyps: hyperplastic polyps, sessile serrated adenomas, and traditional serrated 
adenomas. The first are common large polyps, with BRAF or KRAS mutation and are 
usually not considered potential malignant precursors. In sessile serrated adenomas, the 
initiating event is thought to be a BRAF mutation, while promoter silencing of MLH1 is 
found in adenomas with high-grade dysplasia. Other alterations are found in subsets of 
these types of adenomas, including activation of WNT signalling and methylation of 
MGMT. These lesions are more common on the right side of the colon, more specifically 
in the cecum, ascending colon and transverse colon. The traditional serrated adenomas 
are less frequently found, around 1% of colorectal polyps and are more common in the 
distal side of the colon, sigmoid colon and rectum. These lesions are still poorly 
understood as they are confused with the other types of polyps. KRAS mutation and 
MGMT silencing are common in advanced lesions and CIMP-H has been reported in 
many cases, but BRAF mutations can also be found [Arends, M.J., 2013; Bettington, M., 
et al., 2013]. 
Considering the pathological, molecular, and clinical characteristics of CRC 
tumors, Jass et al. developed a 5 subtype classification for CRC [Jass, J.R., 2007]:  
1) CIMP-H/MSI-H/BRAF mutation; 
2) CIMP-H/MSI-L or microsatellite stable (MSS)/BRAF mutation; 
3) CIMP-L/MSS or MSI-L/KRAS mutation; 
4) CIMP-negative/MSS; 
5) HNPCC/CIMP-negative/MSI-H. 
It is clear now that colorectal cancer is not just one type of disease, it comprises a 
heterogeneous group of diseases. Knowing the characteristics of the tumors can help 
provide better prognostic and treatment options [Bettington, M., et al., 2013; Bogaert, J., 
et al., 2014].  
 
1.6 – Animal models of colorectal cancer 
 
As referred previously, CRC is an accumulation of genetic and epigenetic 
modifications, giving cells advantage to divide uncontrollably. This process is stepwise, 
with diverse intermediates before reaching the carcinoma stage. The various stages of the 
colorectal carcinogenic process can be studied using adequate animal models, 
investigating effects in the different pathways that can be altered. There are several animal 
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models for CRC, and these can be divided into induced and transgenic models, excluding 
the rare cases where CRC develops spontaneously in aged rodents [Johnson, R.L., et al., 
2013; Perse, M., et al., 2011]. Due to the diversity of human CRC, it is difficult to find 
an adequate model for all types of CRC in a single animal model. Nevertheless, animal 
models can be used to study specific alterations important to colon carcinogenesis, as 
long as the model maintains three important characteristics [Johnson, R.L., et al., 2013]: 
1 – The cancer should be limited to organ of interest, in this case the colon, so 
there is no interference with diseases in other organs; 
2 – The lesions studied should be similar to the lesions found in the human form 
of the cancer; 
3 – The models should seize the complex cellular interactions that are important 
for carcinogenesis.  
 
1.6.1 – Chemically induced models - 1,2-dimethylhydrazine/azoxymethane 
Among the induced CRC models, 1,2-dimethylhydrazine (DMH) and 
azoxymethane (AOM) are the chemicals mostly used. Identification of these carcinogens 
was found when large quantities of cycad flour were fed to rats and colon 
adenocarcinomas were found [Rosenberg, D.W., et al., 2009]. Usually, the endpoint of 
studies with these carcinogens are intermediate, pre-neoplastic lesions termed aberrant 
crypt foci (ACF), in short-term studies, or colonic tumors in long-term studies. The 
DMH/AOM model shares many similarities to human sporadic colon cancer, including 
responses to some preventive and promotional agents. Due to this fact, they are widely 
used today to study chemopreventive, dietary and environmental agents. DMH is 
metabolically activated, in the liver, through a cascade of intermediates, including AOM 
and methylazoxymethanol (MAM), until the highly reactive carcinogenic metabolite, 
methyldiazonium ion. Once converted, MAM can enter the blood stream and travel to 
epithelial cells in the colon. In the colon, MAM is metabolized into methyldiazonium ion, 
which, in turn, induces methylation of DNA, increasing loss of epithelial cells by 
apoptosis, increasing proliferation and the rate of mutation. The most important lesion 
this carcinogen generates is O6-methylaguanine, which, can mispair with thymidine, 
resulting in a point mutation, if not repaired correctly [Perse, M., et al., 2011; Rosenberg, 
D.W., et al., 2009; Washington, M.K., et al., 2013]. 
ACF were first visualized by Bird in 1987 [Bird, R.P., 1987] and since then these 
lesions have been used as biomarkers for CRC studies. In the last few years, there have 
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been additional lesions identified as biomarkers, such as dark ACF, flat ACF, mucin-
depleted foci (MDF), and -catenin accumulated crypts (BCAC). ACF can be seen with 
a simple methylene blue staining and have been found in human colon as well as 
carcinogen treated rodents. These lesions are a heterogeneous group, as it is fairly easy to 
find ACF with hyperplasia but it is also possible to find lesions with dysplasia. These 
lesions with dysplasia are accepted as indicators of increased risk for cancer progression 
and, after identification, can be classified as flat ACF or dark ACF, depending on surface 
morphology. When using high-iron diamine alcian blue, one can visualize crypts with 
mucous production. Aberrant crypts with little or no production of mucous are termed 
mucin-depleted foci, and these are dysplastic crypts which share frequent genetic and 
epigenetic alterations with colon cancer. After carcinogen administration, MDF appear 
over a period of around 7 weeks and increase in number and multiplicity with time. BCAC 
are only found with immunohistochemical protocols, searching for -catenin 
accumulation in the nucleus of colon cells. This accumulation is often due to a mutation 
in the -catenin gene, giving these lesions a higher relevance as biomarkers for CRC 
[Perse, M., et al., 2011]. 
In the DMH/AOM model, Apc mutations are found to a lesser extent than -
catenin mutations, although these alterations are only found in neoplastic lesions and have 
not been found in hyperplastic ACF. Apc alterations have been found to be missense or 
truncated point mutations, while -catenin mutations are G to A point transitions in the 
GSK3 phosphorylation motif due to O6-MeG damage. Either mutation gives the same 
result as in human carcinogenesis, inability to phosphorylate -catenin and, therefore, -
catenin accumulation in the nucleus and activation of transcription factors. Kras point 
mutations in codon 12 have been found in hyperplastic lesions, in adenomas and in 
adenocarcinomas of the DMH/AOM animal model, while it is very rare to find p53 
mutations. In this model, Kras mutations have the same effect as in human CRC, 
increased MAPK activation leading to increased proliferation. Also, the frequency of this 
mutation in small adenomas and large adenoncarcinomas is similar to the frequencies 
found in human cancer. This type of alteration has also been found frequently in 
hyperplastic ACF, more than in dysplastic ACF. In human CRC, TP53 mutations are 
frequently found in later stages of the adenoma to carcinoma transition, but in the 
DMH/AOM animal model, this alteration is very rarely found [Perse, M., et al., 2011; 
Takahashi, M., et al., 2004].  
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1.6.2 – Transgenic models 
One of the most used genetically modified animal model is the APCmin/+ mice 
model, a model extensively used to study the prevention, development or treatment of 
CRC with somatic APC alterations. This model was reported in 1990 after a germline 
truncating mutation of Apc was induced with ethylnitrosourea in C57B1/6J mice. These 
mice develop multiple intestinal neoplasms or “Min”, where most tumors appear in the 
small intestine rather than in the large intestine in heterozygotic mice. Although this 
difference in the model compared to human FAP, the phenotypic and histopathological 
features are similar to those found in colon tumors in FAP patients, so this model is widely 
used in studies to understand the role of APC mutation in cancer. As in FAP, loss of the 
functional protein in the second allele is needed for adenoma formation [Johnson, R.L., 
et al., 2013; Suman, S., et al., 2012].  
Another model for the study of hereditary CRC, FAP, is the Pirc (polyposis in the 
rat colon) rat, which was also induced by ethylnitrosourea in F344 rats. This model 
harbors a heterozygous point mutation at the Apc gene that results in a truncated protein. 
These rats develop adenomas throughout the intestine and colon and they mimic the 
morphology of human adenomas and the progression to invasive adenocarcinoma 
sequence. In homozygotes, this mutation is embryonic lethal, while in the heterozygous, 
animals become mortally ill in less than a year [Johnson, R.L., et al., 2013; Washington, 
M.K., et al., 2013].  
Heterozygous or homozygous mice for DNA MMR genes are also used, mostly 
to study Lynch syndrome. Lynch syndrome, as referred before, is an inherited condition 
where cells present a deficient MMR system, usually caused by mutation or epigenetic 
silencing of one of the MMR genes, mainly MLH1 and MSH2. Mouse models lacking 
Mlh1, Msh2 and Msh6 have been developed and tumors are found in the organs of the 
intestinal tract, including colon [Suman, S., et al., 2012]. Mlh1-/- mice develop cancer in 
the intestine and lymphoid tissue, but usually die by the age of 9 months due to this 
phenotype. Msh2 knockout mice develop intestinal tumors after 6 months of age, but often 
die due to lymphomas. Crossing mice that are Mlh1 or Msh2 knockout with heterozygous 
mutated Apc mice increase intestinal carcinogenesis, the same occurring with crossing 
Msh2 and inducible Kras mutation, although in this last case there are more tumors in the 
small intestine than the colon [Johnson, R.L., et al., 2013].  
As most of these models only show the effects of one type of alteration, and as 
carcinogenesis is an accumulation of genetic modifications, investigators are crossing 
Chapter 1                                                                                                                         General introduction 
 
25 
 
different rodent strains, generating models representing key molecular events involved in 
CRC, for example, the MMR deficiency (Msh2-/-) in combination with APCMin/+. Due to 
the complexity of CRC, there seems to be no one ideal animal model to study all the 
genetic and epigenetic alterations that can lead to CRC. With this in mind, the selection 
of the appropriate model to use in compound chemopreventive/therapeutic studies is 
important to correctly understand the mechanistic, preventive or therapeutic action of the 
compound [Johnson, R.L., et al., 2013; Suman, S., et al., 2012].  
 
2 – Diet and cancer 
 
2.1 – General concepts 
 
A large percentage of the etiology of colorectal cancer has been attributed to 
factors associated with lifestyle, such as obesity, lack of physical activity, smoking habits, 
and most importantly, diet. Modification of these factors may, therefore, be beneficial for 
prevention of the disease [Andersen, V., et al., 2013]. Diet seems to have a major role not 
only on the onset of the disease, but also in the possible chemoprevention. 
Chemoprevention can be considered the use of natural or synthetic compounds to prevent 
or delay the development of a disease and the fact that one of the risk factors of CRC is 
diet makes this disease an excellent case for chemoprevention studies. Animal studies 
give us the opportunity to test the role of environmental factors, such as dietary 
constituents, in the prevention or progression of colon cancer. The concept of colon 
cancer prevention involves inhibition, regression or elimination of precancerous lesions, 
reducing the incidence of cancer. It has been seen that bioactive dietary compounds may 
alter the expression of certain genes involved in a variety of cellular events and regulatory 
processes [Andersen, V., et al., 2013].  
Diet may also have adverse effects on colon cancer, being one of the main risk 
factors of this disease [Andersen, V., et al., 2013; Durko, L., et al., 2014; Yusof, A.S., et 
al., 2012]. Red and processed meat has been associated with increased risk of CRC. 
Several hypotheses have been suggested for the reason behind this association, such as 
high heme intake, which induces ROS and these induce mutations and expression of 
cytokines, the production of malondialdehyde, a lipid peroxidation product, or the 
production of heterocyclic amines and N-nitroso compounds [Durko, L., et al., 2014; 
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Oostindjer, M., et al., 2014]. Also, diets with high intake of saturated fats are associated 
with CRC incidence. A proposed mechanism for this risk factor is the stimulation of bile 
acids discharge. Although bile acids are needed for proper digestion, some have been 
shown to be CRC promoters. The next section will explain bile acids and the mechanism 
for tumor promotion [Barrasa, J.I., et al., 2013].  
 
2.2 – Bile acids 
 
It is known that diet is one of the risk factors of colon cancer development. 
Research has shown that high saturated fat intake increases the risk of CRC. This effect 
seems to be related with the increase of endogenous cholesterol biosynthesis that, when 
combined with exogenous cholesterol intake, can lead to increased bile acid biosynthesis. 
Fatty acids have the ability to irritate the colon and induce a local inflammatory response, 
increasing the production of ROS or reactive nitrogen species (RNS) in colon cells. High 
ingestion of fats also stimulate the release of bile acids, which induce an increase in cell 
proliferation, acting as promoters of CRC. It has been shown that there is an increase of 
fecal bile acid concentrations in individuals with increased risk for CRC [Bernstein, H., 
et al., 2009]. 
Bile acids are natural detergents that facilitate the uptake of lipids and fat-soluble 
vitamins. The primary bile acids cholic (CA) and chenodeoxycholic acid (CDCA) are 
synthesized in the liver from cholesterol and high intake of fat induces the release of these 
bile acids into the small intestine, after conjugation with glycine or taurine. The bile salts 
are then actively absorbed in the ileum and return to the liver, by the enterohepatic 
circulation, although some bile salts are able to escape this process and enter the colon. 
In the colon, these bile salts suffer various enzymatic reactions, such as deconjugation 
and dehydroxylation, by bacteria in the colonic lumen, forming secondary bile acids, such 
as deoxycholic (DCA) and lithocholic acid (LCA). Ursodeoxycholic acid (UDCA) is also 
formed by the gut microbiota by epimerization of CDCA [De Preter, V., et al., 2011; 
Payne, C.M., et al., 2008]. A representation of the chemical structures of the bile acids 
are shown in Figure 9. 
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Figure 9 – Representation of the chemical structures of the different bile acids referred in the text. 
 
It has been found that it is possible that the bacteria in the colonic lumen can 
influence multiple processes involved in colon carcinogenesis. There has been a link 
between bacteria and production of toxic and genotoxic metabolites that affect colon cell 
signal transduction. Also, carcinogenic agents can be formed during bacterial 
transformation in the gut. There is a higher bacterial density in the colon than in the small 
intestine. In 1975, the first study showing the link between gut microbiota and colon 
carcinogenesis was by Reddy et al. [Reddy, B.S., et al., 1975]. In this study, Reddy 
demonstrated that only 20% of germ-free rats developed colon cancer after treatment with 
a chemical inducer, while in conventionally maintained rats 93% developed colon tumors. 
There are several strains of bacteria found in the human intestine, and some of these 
strains have been implicated in the development of cancer, such as Streptococcus bovis, 
Bacteriodes spp, Clostridia spp, and H. pylori, while other strains have been shown to 
have the opposite effect, such as Lactobacillus acidophilus and Bifidobacetrium longum. 
For example, S. bovis has been shown to induce increase of proliferation in colonic crypts 
and increase proliferation markers in carcinogen-treated rats [Ellmerich, S., et al., 2000]. 
Also, it seems that diet has a high impact on the type of strains present in the microbiota. 
Gut microbiota appears to increase colon cancer risk by inducing inflammation, 
generating reactive metabolites, which can induce damage, and converting primary bile 
acids to tumor promoting secondary bile acids [Del Chierico, F., et al., 2014; Zhu, Q., et 
al., 2013].  
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Secondary bile acids have been shown to be promoters of colon carcinogenesis. 
Although concentration of bile acids in the colon are relatively low, compared to 
concentrations in the gall bladder or small intestine, some secondary bile acids, such as 
DCA, can achieve concentrations of 700 to 800 µM in the cecum with high-fat diets or 
pathological anomalies [Barrasa, J.I., et al., 2013]. In vivo, deoxycholic acid promotes 
growth of ACF and increases translocation of -catenin to the nucleus, which provides 
an increase of proliferation [Flynn, C., et al., 2007]. Nevertheless, the effects of secondary 
bile acids to the promotion of carcinogenesis are vast. One of the first immediate effects 
of bile acids to colon cells is the induction of ROS and RNS. This increase can be caused 
by damage to mitochondria or by release of arachidonic acid from the cell membrane and, 
consequently, ROS production by partial reduction of O2. Also, DCA has been found to 
activate NF-B in colon cells. This activation may induce and increase nitric oxide 
synthase 2, which generates NO. The production of ROS/RNS increases DNA damage 
and, consequently, favors the appearance of mutations. With the increase of ROS/RNS, 
it is possible to conclude that bile acids can induce DNA damage and cause mutation 
while decreasing DNA repair enzymes, which expression decreases with the increase of 
oxidative stress [Bernstein, H., et al., 2009; Payne, C.M., et al., 2008]. 
DCA has been shown to produce more damage to the cell membrane than any 
other bile acids and their conjugates. It was found that DCA alters membrane 
composition, through redistribution of cholesterol, and microdomains, dysregulates 
membrane-bond receptors, and activates surface enzymes, such as epidermal growth 
factor receptor and protein kinase C. The activation of these surface proteins can be the 
cause for DCA modulation of signaling pathways [Jean-Louis, S., et al., 2006]. Other 
effects that have been found to be due to bile acid exposure are micronuclei formation, 
induction of endoplasmic-reticulum stress, and consequently apoptosis, autophagy or 
necrosis [Barrasa, J.I., et al., 2013; Payne, C.M., et al., 2008]. 
On the other hand, UDCA, a less hydrophobic bile acid, has been shown in several 
publications that it has chemopreventive potential. This compound was initially used for 
treatment of gallstones and primary biliary cirrhosis. UDCA not only has different 
biological effects than DCA, but can also inhibit DCA’s deleterious effects. In one study, 
it was found that UDCA is able to inhibit cell proliferation in a colon cancer cell line, 
suppressing c-Myc expression [Peiro-Jordan, R., et al., 2012]. In other studies, UDCA 
was found to inhibit DCA-induced apoptosis in HCT116 colon cancer cell line [Im, E., et 
al., 2004; Powell, A.A., et al., 2006]. This same group also demonstrated that UDCA can 
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induce differentiation in colon cancer cells by inducing histone hypoacetylation [Akare, 
S., et al., 2006]. In high-risk populations, UDCA was also found to decrease the risk of 
colorectal cancer development. In animal models, UDCA was found to inhibit Ras 
mutations and cyclooxygenase-2 expression in AOM-induced carcinogenesis. As UDCA 
is a hydrophilic bile acid and DCA has a hydrophobic character, the differences in mode 
of action could be due to the hydrophilicity of the compounds [Barrasa, J.I., et al., 2013]. 
 
2.3 – Natural compounds 
 
Natural products have been shown to be promising agents that may play a role in 
cancer prevention as well as in cancer therapy, by modulating common signaling 
pathways in cancer development, but also in DNA damage prevention or repair. So, 
chemoprevention can be targeted to specific molecular processes. Many epidemiological 
studies have found a correlation between consumption of fruits and vegetables and the 
decrease risk of CRC.  
Folic acid (vitamin B9) is not synthesized by the human organism, so its source is 
fruits and dark green vegetables. It has been found that deficiency of this vitamin is linked 
to increased colorectal lesions, while supplementation correlates with decreased risk in 
patients with ulcerative colitis. The assumed molecular mechanisms for folic acid CRC 
prevention include DNA synthesis and repair, but also the methylation state of genes. 
Epidemiological studies have shown also an association of folic acid and decreased colon 
carcinogenesis [Link, A., et al., 2010].  
Polyphenols have been shown to have a wide variety of beneficial effects for 
overall human health. Curcumin has antioxidant, anti-inflammatory and anticarcinogenic 
properties and has been found to inhibit cell invasion and decrease DNMT activity, 
reducing gene silencing [Link, A., et al., 2010; Vanden Berghe, W., 2012]. Quercetin, a 
flavonol, has been found to interact with β-catenin, decreasing cell proliferation, but also 
to inhibit HAT activity, reducing gene expression [Pericleous, M., et al., 2013; Vanden 
Berghe, W., 2012]. Quercetin has also been found to suppress ACF formation in a colon 
cancer induced model [Bordonaro, M., et al., 2014; Warren, C.A., et al., 2009]. It was 
found that (-)-epigallocatechin-3-gallate (EGCG), a major polyphenolic compound from 
green tea, inhibits DNMT activity and reactivates methylation-silenced genes present in 
cancer cells, such as MGMT and hMLH [Fang, M.Z., et al., 2003]. The chemical 
structures of some natural compounds are shown in Figure 10.  
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Figure 10 – Representation of the chemical structures of the different natural compounds referred in the 
text. 
 
Studies in our lab have demonstrated other effects of diet on CRC prevention: at 
the level of DNA protection and/or induction of repair and of molecular targets of cell 
proliferation and death. These studies demonstrated that ursolic acid and luteolin protect 
DNA from oxidative damage, increase DNA repair activity [Ramos, A.A., et al., 2010b], 
but also have antiproliferative and proapoptotic effects [Xavier, C.P., et al., 2009b]. Also, 
extracts from the plant genius Salvia had chemopreventive potential by stimulating DNA 
repair and protecting cells against oxidative DNA damage in Caco-2 [Ramos, A.A., et al., 
2010a] and in CO115 and HCT15 [Ramos, A.A., et al., 2012]. In another study, these 
extracts induced apoptosis and inhibited cell proliferation by interfering in the MAPK 
signaling pathway [Xavier, C.P., et al., 2009a]. 
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Alterations in lifestyle and diet can help lower colorectal incidence and/or 
progression. The introduction of foods with compounds that have chemopreventive 
activity can also aid in the prevention of CRC. The introduction of a healthy dietary 
pattern and good lifestyle habits would not only bring benefits for colorectal cancer 
prevention, but also the overall health of the individual.  
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1 - Effects of deoxycholic acid and ursodeoxycholic acid in Caco-2 cells 
 
1.1- Introduction 
 
Bile acids are amphiphilic acidic steroids which are synthesized from cholesterol 
in the liver, originating cholic and chenodeoxycholic acid as primary bile acids. After 
synthesis, these bile acids are conjugated with taurine or glycine, generating taurocholic 
or glycocholic acid and taurochenodeoxcholic or glycochenodeoxycholic acid, 
respectively, and released into the bile. In the intestine, bile acids aid in fat digestion and 
absorption and protect lipolytic enzymes from proteolytic degradation. Intestinal 
microflora metabolize bile acids converting them into secondary bile acids, for example, 
deoxycholic acid (DCA) [Bernstein, H., et al., 2009; Zhu, Q., et al., 2013]. Deoxycholic 
acid has been associated with increased risk of colon cancer development, whereas 
ursodeoxycholic acid (UDCA), also produced in the gut by the microflora, has been 
associated as a chemopreventive compound [Barrasa, J.I., et al., 2013; Bernstein, H., et 
al., 2009].  
It is known that the content of the intestinal lumen is dependent on diet and a diet 
with high saturated fat intake stimulates bile acid discharge. The constant exposure to 
high levels of bile acids in the large intestine can have two main consequences that may 
explain bile acid promotion of colorectal cancer: promotion of DNA damage by oxidative 
stress and selective growth of apoptotic-resistant cells. The apoptotic effect of bile acids 
on hepatocytes has been extensively studied, but there is also an interest on the cellular 
effects of these compounds on colonocytes and colon cancer. There are already several 
studies that have shown the effect of bile acids, especially DCA, in the promotion of colon 
carcinogenesis, but also the potential of being carcinogens themselves [Bernstein, C., et 
al., 2011; Flynn, C., et al., 2007; Payne, C.M., et al., 2010]. In colon cancer cell lines, 
various studies have shown some mechanisms on how DCA or UDCA can affect cell 
proliferation and apoptosis [Glinghammar, B., et al., 2002; Im, E., et al., 2004; Jean-
Louis, S., et al., 2006; Powell, A.A., et al., 2006; Qiao, D., et al., 2001].  
In this study, we used Caco-2 cells, a human colonic adenocarcinoma cell line, to 
study the effects of DCA and UDCA in cell proliferation, apoptosis and DNA damage. 
Most studies use HCT116 or HT29 cell lines to study the impact of bile acids on colon 
cells, however these cell lines harbor various genetic or epigenetic alterations in the 
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MAPK signaling pathways, giving us information on the effect of bile acids in tumor cells. 
Caco-2 cells are microsatellite stable, mismatch repair proficient, and KRAS and BRAF 
wild-type, having characteristics closer to normal colonocytes. 
 
1.2 – Material and methods 
 
1.2.1 – Reagents and antibodies 
N-Methyl-N-nitrosourea (MNU), O6-benzylguanine (BG), thiazolyl blue 
tetrazolium bromide (MTT), DCA, UDCA, Dulbecco’s modified Eagle medium 
(DMEM), penicillin/streptomycin, and trypsin solution were purchased from Sigma–
Aldrich (St. Louis, MO, USA). Fetal bovine serum (FBS) was purchased from Biochrom 
KG (Berlin, Germany). SYBR Gold (nucleic acid gel stain) was from Invitrogen 
Molecular Probes (Eugene, OR, USA). The protein quantification DC protein assay was 
purchased from Bio-Rad Laboratories (Hercules, CA, USA). Primary antibodies were 
purchased from the following sources: anti-actin was purchased from Sigma–Aldrich; 
anti-JNK, anti-phospho-JNK, anti-phosphoERK1/2, anti-K-Ras, anti-B-Raf, anti-MGMT, 
anti-MLH1 Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA); and anti-p44/42 
MAPK (ERK1/2), anti-phospho-Akt (ser473), and anti-Akt from Cell Signaling (Danvers, 
MA, USA). Peroxidase-conjugated goat anti-mouse antibody and Immobilon Western 
blotting detection reagents were purchased from Santa Cruz Biotechnology (Santa Cruz, 
CA, USA) and Millipore (Billerica, MA, USA), respectively. All other reagents and 
chemicals used were of analytical grade. 
 
1.2.2 – Cell line and culture conditions 
Caco-2 cells, derived from human colon carcinoma, were maintained as 
monolayer cultures in DMEM supplemented with 10% FBS and antibiotics (100 U/mL 
penicillin and 100 mg/mL streptomycin), under an atmosphere of 5% CO2 at 37 ºC. Cells 
were seeded onto 6- (2 mL) or 12- (1 mL) well plates at a density of 0.1×106 cells/mL. 
Test compounds were added to culture medium to the desired concentration ensuring that 
the DMSO concentration did not exceed 0.5% (v/v); controls received vehicle only. 
 
1.2.3 – Assessment of cell viability/proliferation by MTT reduction test 
A MTT reduction assay was performed in order to evaluate the toxicity of DCA 
and UDCA in this colon cancer cell line. Cells were treated with test compounds for 6, 
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24 and 48 h, including 2 h incubation with MTT (final concentration 0.5 mg/mL). The 
formazan crystals were then dissolved in a solution of DMSO/ethanol (1:1). The number 
of viable cells in each well was estimated by the cell capacity to reduce MTT. The results 
were expressed as percentage relative to the control (cells without any test compound). 
 
1.2.4 – Nuclear condensation assay 
The effects of DCA (500 µM) or UDCA (500 µM) treatment on induction of 
apoptosis in Caco-2 cells was assessed by nuclear condensation assay. The number of 
apoptotic cells was counted after 48 and 72 h as previously described [Xavier, C.P., et al., 
2009]. Staurosporin (STS) at 0.5 µM was used as positive control. At least 500 cells were 
counted and the number of apoptotic cells was divided by the total number cells counted 
to give the percentage of cell death.  
 
1.2.5 – Genotoxicity assay 
 The alkaline version of the single cell gel electrophoresis (comet) assay was used 
to evaluate DNA damage [Collins, A.R., 2004]. Caco-2 cells were incubated for different 
time points (15 min, 30 min, 1 h, 6 h, 24 h and 48 h) at 37 ºC with DCA or UDCA at 
different concentrations (100, 500 and 750 µM). Cells were collected by trypsinization 
and around 50,000 cells were centrifuged for 1 min at 5,000 rpm, ressuspended in low 
melting point agarose and spread onto agarose-coated slide using a cover slip. After 10 
min at 4 ºC, the coverslips were removed and slides were placed in lysis solution (2.5 M 
NaCl, 100 mM Na2EDTA, 10 mM Tris base, pH 10, plus 1% Triton X-100) for 1 h at 4 
ºC. Slides were then placed in a horizontal electrophoresis chamber with electrophoresis 
solution (0.3 M NaOH, 1 mM Na2EDTA, pH > 13) for 40 min at 4 ºC for the DNA to 
unwind before electrophoresis for 20 min at 0.8 V/cm and ∼300 mA. After 
electrophoresis, slides were washed twice with PBS and dried at room temperature (RT). 
For analysis of the comet images, slides were stained with SYBR Gold solution for 30 
min at 4 ºC; after drying, the slides were analyzed using a fluorescence microscope and 
the Comet IV analysis system (Perceptive Instruments Ltd, Haverhill, UK) was used to 
calculate the parameter percentage of DNA in the tail. About 100 randomly selected cells 
were analyzed per sample. 
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1.2.6 – DCFH oxidative stress assay 
The capacity of DCA to induce reactive oxygen species was evaluated using the 
dichlorofluorescin (DCFH) oxidative stress assay. Briefly, culture medium was removed 
and cells were washed with PBS. Afterwards, cells were incubated with 2′,7′-
dichlorofluorescein diacetate (DCF-DA) (100 µM) or DMSO (vehicle) for 30 min at 37 
ºC. This solution was removed and cells were washed with PBS. Cells were then 
incubated with DCA (500 µM) or tert-butyl hydroperoxide (200 µM), diluted in serum-
free medium, for 30 min at 37 ºC. The compounds were removed and cells were lysed 
with a solution of 90% DMSO/10% PBS for 10 min at RT in the dark. Fluorescence was 
read at 520 nm upon excitation at 485 nm.  
 
1.2.7 – Western blot analysis 
Cells were incubated with DCA or UDCA (500 µM) for 6, 24 and 48 h. Total cell 
lysates were prepared to measure expression of different proteins. The cells were washed 
with PBS 1x and lysed for 5 min at 4 °C with ice-cold RIPA buffer (1% NP-40 in 150 
mM NaCl, 50 mM Tris (pH 7.5), 2 mM EDTA) supplemented with 20 mM NaF, 1 mM 
phenylmethylsulfonyl fluoride, 20 mM Na3VO4 and protease inhibitor cocktail (Roche, 
Mannheim, Germany). Protein concentration was quantified using the DC protein assay 
following the manufacturer’s instructions, and 20 µg/well was separated by 12% SDS–
PAGE and transferred to polyvinylidene difluoride membranes. Membranes were 
blocked and incubated with primary antibody overnight. After washing, membranes were 
incubated with secondary antibody conjugated with IgG horseradish peroxidase for 1 h, 
and immunoreactive bands were detected using the Immobilon solutions (Millipore, 
Billerica, MA, USA) under a chemiluminescence detection system (Chemi Doc XRS; 
Bio-Rad Laboratories, Inc.). 
Band area intensity was quantified using the Quantity One software from Bio-
Rad. β-Actin was used as loading control. 
 
1.2.8 – Statistical analysis 
Statistical analyses were done using t test, one-way or two-way analysis of 
variance, using GraphPad Prism 4.0 software, when appropriate (San Diego, CA, USA). 
P values ≤0.05 were considered statistically significant. All results are presented as mean 
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± SEM of at least three independent experiments. Images are representative of three 
independent experiments. 
 
1.3 – Results and discussion 
 
 In this study, we evaluated the effect of two bile acids, deoxycholic acid and 
ursodeoxycholic acid, on proliferation and DNA damage in Caco-2 cell line. One of the 
most used cell lines is HCT116, but as this cell line has many alterations in signaling 
pathways and DNA damage repair pathways, it gives us evidence of the effects of bile 
acids in tumor cells. Caco-2 cell line has fewer alterations in key pathways and has 
functional O6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair 
systems, giving more information on possible mechanisms in normal colonocytes. Few 
studies have used Caco-2 for the evaluation of bile acids effects. In this study, high 
concentrations (500 and 750 µM) of DCA induced cell death at 24 and 48 h of treatment 
(Figure 1). This data is in accordance with a study by Milovic, V et al., where they found 
that apoptosis was induced with higher concentrations of the same bile acid, in Caco-2 
cell line [Milovic, V., et al., 2002]. We also tested a hydrophilic bile acid, UDCA, which 
is considered to be protective against colon carcinogenesis. With this bile acid, we found 
no significant effects on cell proliferation at any of the incubation times or the 
concentrations tested (Figure 1). Krishna-Subramanian et al., have shown that, in IEC-6 
intestinal cells, a 72 h incubation of UDCA induced growth arrest of these cells [Krishna-
Subramanian, S., et al., 2012]. They used the IEC-6 cell line due to the fact that this cell 
line mimicked the effects of UDCA in epithelial colonic cells from mice, while HCT116 
and HCT8 did not. As seen in Figure 1, for 750 µM of UDCA we also see a slight 
tendency (22%) of decreased proliferation with 48 h incubation. This tendency could 
suggest an effect of inhibition of proliferation of UDCA in this cell line, similar to the 
effects seen with the IEC6 cell line.  
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Figure 11 – The effect of different concentrations (750, 500 and 100 µM) of DCA and UDCA on cell 
viability at 6, 24 and 48 h, in Caco-2 cells. Cell viability was measured by the MTT assay and results are 
the mean ± SEM of at least 3 independent experiments. *P≤ 0.05 and ***P≤ 0.001, when compared with 
control were determined by one-way ANOVA followed by Newman-Keuls multiple comparison test. 
  
 As we found that 500 µM of DCA decreased cell proliferation, and this 
concentration is widely used in other studies, we tested this concentration for induction 
of cell death and for comparative reasons, the same concentration of UDCA was used. 
After 72 h incubation of DCA, there was a significant increase of cell death, while UDCA 
treatment showed no effect at this concentration (Figure 2). It has been reported that DCA 
is a stress inducer, causing membrane alterations, DNA damage, mitotic stress, and other 
perturbations, ultimately leading to apoptosis in various cancer cell lines [Payne, C.M., 
et al., 2008]. In cancer cells, as survival pathways are usually activated, apoptosis is 
evaded, so with this cell line we have a result possibly similar to what happens in normal 
cells. 
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Figure 12 – Effects of DCA, 500 µM, and UDCA, 500 µM, on apoptosis induction in Caco-2 cells. 
Apoptosis was measured by the TUNEL assay after 48 and 72 h incubation with the compounds. 
Staurosporin (STS) at 0.5 µM was used as a positive control. Results are expressed as mean ± SEM of at 
least 3 independent experiments. *** P≤ 0.001, ## P≤ 0.01 and ### P≤ 0.001, when compared with 
respective control, were determined by two-way ANOVA followed by Bonferroni post-tests.  
 
As it was found that DCA induces apoptosis, then it could be speculated that some 
kind of stress is being induced. Cells are under constant attack from reactive oxygen 
species (ROS) and alkylating species generated from endogenous and exogenous sources. 
It is known that high concentrations of bile acids, caused by high intake of fat, in the 
colon lumen provides a stressful environment, disrupting the normal cellular redox 
homeostasis, favoring an oxidant state. This redox state may also help the selection of 
mutated cells that survive this type of environment, propagating the mutator phenotype 
and increasing the chances of colon cancer development [Payne, C.M., et al., 2008; 
Ramos, A.A., et al., 2011]. ROS can damage molecules in the cell, such as proteins, lipids, 
and DNA, resulting in metabolic deregulation. DNA damage is a significant consequence 
of ROS and alkylating agents attack and is considered to be involved in the development 
of mutations and cancer [Payne, C.M., et al., 2008]. The ability of DCA and UDCA to 
induce DNA damage was measured using the Comet assay (Figure 3). UDCA did not 
induce DNA damage at any of the time points or concentrations used. DCA induced DNA 
damage after 1, 6 and 24 h incubation at the highest concentration used, 750 µM. At 48 h 
incubation, it seems that either the cells are repairing the damage or are redirecting to cell 
death, as the level of DNA damage begins to decrease.  
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Figure 3 – Effects of different concentrations (100, 500, and 750 µM) of DCA and UDCA on DNA damage 
induction in Caco-2 cells. DNA damage was measured by the comet assay at different time points (15 min, 
30 min, 1, 6, 24, and 48 h). Results are expressed as mean ± SEM of at least 3 independent experiments. 
*P≤ 0.05 when compared with respective control was determined by one-way ANOVA followed by 
Newman-Keuls multiple comparison test. 
 
We also evaluated the potential of DCA to induce ROS to find a possible cause 
for the DNA damage seen by the comet assay. As UDCA did not induce any kind of 
damage, we did not use this compound in this assay. Treatment with 500 µM of DCA for 
30 min produced significantly more ROS when compared with control, and comparable 
to the positive control used (Figure 4). It has been shown that DCA induces ROS 
production in other cell lines, such as Barrett's epithelial cells [Huo, X., et al., 2011] and 
HCT-116 [Smith, A.F., et al., 2012]. So, in our model, DCA is inducing DNA damage, 
at least in part, by ROS production.  
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Figure 4 – Effects of DCA (500 µM) on the production of ROS. Results are expressed as mean ± SEM of 
at least 3 independent experiments. ROS production was measured by DCFH oxidative stress assay and 
tert-butyl hydroperoxide (200 µM) was used as postive control. *P≤ 0.05 when compared with control was 
determined by one-way ANOVA followed by Newman-Keuls multiple comparison test. 
 
 Increased DNA damage by bile acids may be due, in part, to the decrease in DNA 
repair enzymes. O6MeG, a highly mutagenic lesion, is corrected by the MGMT protein. 
If there is a problem with the MGMT protein, then the lesion will cause a mispair in the 
DNA and then the mismatch repair system (MMR) will recognize it and excise the 
mispair. MGMT and MLH1, a protein from MMR system, are commonly altered in colon 
carcinogenesis. So, the effect of the two bile acids on the protein expression of these two 
repair enzymes was assessed (Figure 5). We found a significant effect of DCA on MLH1 
expression at 48 h incubation, a slight decrease of MLH1 expression, while UDCA 
showed a tendency (26.13%) to decease the expression of this protein. There was a 
significant decrease of MGMT expression by both bile acids after 48 h incubation. It has 
been shown that bile acids can modulate the expression of some DNA repair enzyme, 
either directly or by oxidative stress [Payne, C.M., et al., 2008]. With our results, we 
found that deoxycholic acid decreases the expression of MGMT and MLH1 over time. 
The decrease of the expression of these proteins can be the source of deoxycholic acid 
cancer promotion effect, not causing DNA damage itself, but modulating the expression 
of a key enzyme in DNA repair, which are important for repair of highly mutagenic 
lesions, such as O6methylguanine [Nyskohus, L.S., et al., 2013]. We also found that 
UDCA decreases significantly MGMT expression.  
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Figure 5 – Effects of treatment with DCA and UDCA (500 µM) for 6, 24, and 48 h on MLH1 and MGMT 
protein expression in Caco-2 cells, using western blot. A representative blot is shown under the 
quantification. β-actin was used as loading control. Values are mean ± SEM of at least three independent 
experiments. *P ≤ 0.05 when compared to control was determined by one-way ANOVA followed by 
Newman-Keuls multiple comparison test. 
  
As bile acids can modulate signaling pathways involved in cell proliferation and 
apoptosis, we investigated the expression of some key players in the MAP kinase 
signaling pathway. We found no significant effects of DCA or UDCA on BRAF and 
KRAS expression (Figure 6). The expression of phospho-ERK and phospho-JNK was 
also evaluated and an increase of phospho-ERK at 6 and 24 h incubation was observed, 
while no effects were seen in phospho-JNK (Figure 8). It has been demonstrated that in 
HCT116, DCA activates phospho-ERK, but not phospho-JNK [Qiao, D., et al., 2001], 
while in a more recent study by Zeng, H. et al., in the same cell line, they found activation 
of phospho-ERK and phospho-JNK [Zeng, H., et al., 2010]. In the cell viability assay, we 
found no significant effects on increase or decrease of proliferation at 6 h incubation, but 
it seems that the MAPK/ERK pathway is activated. As KRAS is a membrane anchored 
protein and bile acids have been found to perturb the cell membrane [Jean-Louis, S., et 
al., 2006], there could be alterations in the membrane composition and this effects KRAS 
expression. This would possible decrease the activation of the MAPK/ERK pathway, 
opposite of the effects in this study. One hypothesis to explain our results is that DCA has 
been shown to activate PKC pathway, and this pathway can activate MAPK/ERK via 
BRAF, without KRAS involvement [Wu, J., et al., 2008]. Also, the effect of the bile acids 
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on phospho-AKT was investigated and there was also an increase by the bile acids of the 
expression of this protein (Figure 7). So, although DCA induces cell death to some cells, 
as seen by the cell viability assay, it activates proliferation and cell survival in other cells, 
seen by induction of MAPK/ERK and PI3K/AKT signaling pathways, respectively.  
 
 
Figure 6 – Effects of treatment with DCA and UDCA (500 µM) for 6, 24, and 48 h on BRAF and KRAS 
protein expression in Caco-2 cells, using western blot. A representative blot is shown under the 
quantification. β-actin was used as loading control. Values are mean ± SEM of at least three independent 
experiments.  
 
In conclusion, our study showed that, in Caco-2 cells, DCA induces cell death at 
high concentrations. This cell death can be, in part, due to DNA damage and decrease of 
DNA repair. Also, although DCA induces cell death, it also induces cell growth and 
survival in the remaining cells by activation of the MAPK/ERK and PI3K/AKT signaling 
pathways. In our study, UDCA did not induce apoptosis or DNA damage in this cell line, 
but did decrease DNA repair enzymes. This decrease is a characteristic of carcinogenesis 
and not chemoprevention. Also, UDCA activated the same signaling pathways that DCA 
did, this suggesting increased proliferative potential. These effects are characteristic of 
carcinogenesis and not chemoprevention. High levels of DCA appear to induce rapid cell 
turnover in the colon and this can be beneficial for propagation of a mutator phenotype.  
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Figure 7 – Effects of treatment with DCA and UDCA (500 µM) for 6, 24, and 48 h on phospho-ERK, 
phospho-JNK and phospho-AKT protein expression in Caco-2 cells, using western blot. A representative 
blot is shown under the quantification. The total protein was used to normalize the values. Values are mean 
± SEM of at least three independent experiments. *P ≤ 0.05 when compared to control. 
 
2 – Effects of UDCA pretreatment on DCA induced alterations 
 
2.1 – Introduction 
  
Hydrophobic bile acids, such as deoxycholic acid (DCA), has been shown to be 
linked to colon carcinogenesis as a promotor and also as an inducer. But more hydrophilic 
bile acids, such as ursodeoxycholic acid (UDCA), are considered cytoprotective and is 
used in the treatment of some diseases [Barrasa, J.I., et al., 2013]. It is known that the 
cytoprotective effect of UDCA may be due to the reduction of the apoptotic threshold 
through the classical mitochondrial pathways. In HCT116 cell line, it has been found that 
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UDCA induces differentiation and senescence, inhibits DCA-induced activation of 
EGFR/Raf-1/ERK signaling pathway and suppresses the apoptosis induced by high 
concentrations of DCA [Amaral, J.D., et al., 2009; Barrasa, J.I., et al., 2013]. Also, 
UDCA can protect HCT116 cells against DCA-induced apoptosis by stimulating AKT 
pathway [Im, E., et al., 2005]. But, HCT116 has an activating mutation in the KRAS gene 
[Ahmed, D., et al., 2013], so these effects are tumor-related. Caco-2 cell line has no 
mutation in the EGFR/Raf-1/ERK nor the PI3K/AKT pathways.  
 In this study, we evaluated the pretreatment for 48 h of UDCA on cell death and 
activation of signaling pathways induced by DCA. We used Caco-2 cell line, which does 
not harbor KRAS or BRAF mutations, to give us some evidence on how UDCA affects 
DCA alterations in a “normal” colon cell.  
 
2.2 – Material and methods 
 
2.2.1 – Reagents and antibodies 
DCA, UDCA, Dulbecco’s modified Eagle medium (DMEM), 
penicillin/streptomycin, and trypsin solution were purchased from Sigma–Aldrich (St. 
Louis, MO, USA). Fetal bovine serum (FBS) was purchased from Biochrom KG (Berlin, 
Germany). The protein quantification DC protein assay was purchased from Bio-Rad 
Laboratories (Hercules, CA, USA). Primary antibodies were purchased from the 
following sources: anti-actin was purchased from Sigma–Aldrich; anti-JNK, anti-
phospho-JNK, anti-phosphoERK1/2, anti-K-Ras, anti-B-Raf, anti-MGMT, anti-MLH1 
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA); and anti-p44/42 MAPK 
(ERK1/2), anti-phospho-Akt (ser473), and anti-Akt from Cell Signaling (Danvers, MA, 
USA. Peroxidase-conjugated goat anti-mouse antibody and Immobilon Western blotting 
detection reagents were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, 
USA) and Millipore (Billerica, MA, USA), respectively. All other reagents and chemicals 
used were of analytical grade. 
 
2.2.2 – Cell line and culture conditions 
Caco-2 cells, derived from human colon carcinoma, cells were maintained as 
monolayer cultures in DMEM supplemented with 10% FBS and antibiotics (100 U/mL 
penicillin and 100 mg/mL streptomycin), under an atmosphere of 5% CO2 at 37 ºC. Cells 
were seeded onto 6- (2 mL) well plates at a density of 0.1×106 cells/mL. Test compounds 
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were added to culture medium to the desired concentration ensuring that the DMSO 
concentration did not exceed 0.5% (v/v); controls received vehicle only. 
 
2.2.3 – Nuclear condensation assay 
The effects of 48 h pretreatment with UDCA (500 µM) before incubation with 
DCA (500 µM) for 72 h on induction of apoptosis in Caco-2 cells was assessed by nuclear 
condensation assay. The number of apoptotic cells was counted as previously described 
[Xavier, C.P., et al., 2009]. At least 500 cells were counted and the number of apoptotic 
cells was divided by the total number cells counted to give the percentage of cell death. 
 
2.2.4 – Western blot analysis 
Cells were incubated with UDCA (500 µM) or medium for 48 h. Then, medium 
was removed and DCA (500 µM) was added for 6, 24 and 48 h. Total cell lysates were 
prepared to measure expression of different proteins. The cells were washed with PBS 1x 
and lysed for 5 min at 4 °C with ice-cold RIPA buffer (1% NP-40 in 150 mM NaCl, 50 
mM Tris (pH 7.5), 2 mM EDTA) supplemented with 20 mM NaF, 1 mM 
phenylmethylsulfonyl fluoride, 20 mM Na3VO4 and protease inhibitor cocktail (Roche, 
Mannheim, Germany). Protein concentration was quantified using the DC protein assay 
following the manufacturer’s instructions, and 20 µg/well was separated by 12% SDS–
PAGE and transferred to polyvinylidene difluoride membranes. Membranes were 
blocked and incubated with primary antibody overnight. After washing, membranes were 
incubated with secondary antibody conjugated with IgG horseradish peroxidase for 1 h, 
and immunoreactive bands were detected using the Immobilon solutions (Millipore, 
Billerica, MA, USA) under a chemiluminescence detection system (Chemi Doc XRS; 
Bio-Rad Laboratories, Inc.). 
Band area intensity was quantified using the Quantity One software from Bio-Rad. 
β-Actin was used as loading control. 
 
2.2.5 – Statistical analysis 
Statistical analyses were done using t-test, one-way or two-way analysis of 
variance using GraphPad Prism 4.0 software, when appropriate (San Diego, CA, USA). 
P values ≤0.05 were considered statistically significant. All results are presented as mean 
± SEM of at least three independent experiments. Images are representative of three 
independent experiments. 
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2.3 – Results and discussion 
 
UDCA has been shown to inhibit DCA-induced alterations in HCT116 cell line. 
We evaluated the effect of 48 h pretreatment with UDCA (500 µM) on DCA-induced cell 
death in Caco-2 cell line (Figure 8). DCA induced an increase of cell death at 72 h 
incubation. UDCA alone did not induce any kind of cell death, being comparable to the 
control group. When UDCA was given before DCA treatment, there was an increase, 
although not significant when compared with DCA alone, of cell death with the two bile 
acids, which is significant when compared with UDCA alone. In studies with HCT116 
cell line, it was found that UDCA decreased DCA-induced apoptosis in an AKT-
dependent manner [Im, E., et al., 2005; Im, E., et al., 2004]. The difference in the effects 
may be due to the genetic alterations present in the HCT116 cell line that are not present 
in the Caco-2 cell line. This could indicate that there are differences in the effects of 
UDCA in cells with genetic alterations and normal colonocytes. 
The same study showed that UDCA pretreatment reduced the expression of 
phospho-ERK when compared with DCA treatment alone [Im, E., et al., 2004]. The effect 
of pretreatment with UDCA before DCA on the expression of phospho-ERK, phospho-
JNK, and phospho-AKT was also evaluated (Figure 9). In our study, we found no effect 
of pretreatment with UDCA in phospho-ERK expression at 6 h incubation, but at 24 h 
incubation we found a significant decrease in expression. As Caco-2 cells grow slower 
than HCT116, this could account for differences between the time points of these two 
studies. We also evaluated the effect on phospho-JNK and phospho-AKT, to compare 
with our previous results and to understand the increase of apoptosis seen with 
pretreatment with UDCA. In our previous study, we found no effect of either bile acid on 
phosphor-JNK expression, but with pretreatment with UDCA before DCA incubation, we 
found an increase in this protein expression at all time points (Figure 9). Upon 
phosphorylation of JNK, this protein enters the nucleus where it activates c-Jun, and this 
activation leads to the formation of AP-1, which, in turn, regulates the expression of 
several proteins, some of them involved in pro-apoptotic signaling [Dhanasekaran, D.N., 
et al., 2008]. As we found an increase in in the number of apoptotic cells with 
pretreatment of UDCA, and we find an increase in phospho-JNK expression, we can 
speculate that possibly, in Caco-2 cells, UDCA treatment before DCA incubation induces 
an increase in apoptosis via JNK pathway and this activation is prolonged until at least 
48 h incubation. This indicates, with the addition of the previous results on the decrease 
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of DNA repair proteins, that in this cell line, UDCA does not have a chemopreventive 
effect. Further studies are needed to support this hypothesis.  
 
 
Figure 8 – The effects of 48 h pretreatment with UDCA (500 µM) before incubation with DCA (500 µM) 
for 72 h on induction of apoptosis in Caco-2 cells. Apoptosis was measured by the nuclear condensation 
assay. Results are expressed as mean ± SEM of at least 3 independent experiments. * P≤ 0.05 when 
compared with control and ## P≤ 0.01 when compared with UDCA alone, were determined by Student’s t-
test. 
 
 In our previous study, we observed an increase of phospho-AKT with both bile 
acid treatments at 6 h. In this study, we observed an increase of the same protein at 6 h 
with DCA alone and pretreatment with UDCA significantly increased when compared 
with DCA (Figure 9). The PI3K/AKT pathway regulates different metabolic pathways, 
but also inhibits apoptosis [Testa, J.R., et al., 2005]. In this case, the effects on JNK 
signaling may be stronger than the effects of AKT signaling, hence having an increase in 
apoptosis.  
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Figure 9 – Cells were incubated with UDCA (500 µM) or medium for 48 h. Then, medium was removed 
and DCA (500 µM) was added for 6, 24 and 48 h. Effects on phospho-ERK, phospho-JNK and phospho-
AKT protein expression in Caco-2 cells were evaluated using western blot. The total protein was used to 
normalize the values. Values are mean ± SEM of at least three independent experiments. *P≤ 0.05, ** P≤ 
0.01 and *** P≤ 0.001 were determined by one-way ANOVA followed by Newman-Keuls multiple 
comparison test. 
 
 We also evaluated the effects of UDCA pretreatment on BRAF, KRAS, MGMT, 
and MLH1 protein expression. No significant effects were found on BRAF and KRAS 
expression (Figure 10) when comparing with DCA treatment alone. With the DNA repair 
enzymes, there was a decrease of expression of both proteins with UDCA pretreatment 
when compared with DCA treatment alone (Figure 11). This could be due to a decrease 
in DNA damage associated to UDCA cytoprotective effects as seen in a study with male 
rats [Rodrigues, C.M., et al., 1998]. In our previous study, we found that DCA and UDCA 
alone decreased MLH1 and MGMT expression. This effect could be an accumulation of 
the effects with each bile acid alone. Studies on UDCA pretreatment on ROS production 
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and DNA damage would clarify this hypothesis. On the other hand, with the increase of 
apoptosis, the cell may be decreasing the production of these proteins, as it directs 
transcription to pro-apoptotic proteins. Further studies are needed to answer these 
questions. 
 
 
Figure 10 – Cells were incubated with UDCA (500 µM) or medium for 48 h. Then, medium was removed 
and DCA (500 µM) was added for 6, 24 and 48 h. Effects on KRAS and BRAF protein expression in Caco-
2 cells were evaluated using western blot. The total protein was used to normalize the values. Values are 
mean ± SEM of at least three independent experiments. 
 
 
Figure 11 – Cells were incubated with UDCA (500 µM) or medium for 48 h. Then, medium was removed 
and DCA (500 µM) was added for 6, 24 and 48 h. Effects on MGMT and MLH1 protein expression in 
Caco-2 cells were evaluated using western blot. The total protein was used to normalize the values. Values 
are mean ± SEM of at least three independent experiments. *P≤ 0.05, ** P≤ 0.01 and *** P≤ 0.001 were 
determined by one-way ANOVA followed by Newman-Keuls multiple comparison test. 
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 In conclusion, in Caco-2 cell line, UDCA enhances apoptosis when given before 
DCA treatment. This increase is accompanied by a prolonged increase in JNK 
phosphorylation. These results contradict some studies that were done in HCT116 cell 
line, but perhaps the genetic background of the two cell lines may account for the 
discrepancy. We found a decrease in phospho-ERK expression, which is in accordance 
with the HCT116 cell line study. UDCA pretreatment also induced a decrease in MGMT 
and MLH1 DNA repair proteins, which needs further studies to explain this effect. UDCA 
has shown potential cytoprotective effects in many studies, but in this study, UDCA 
showed characteristics of promoting potential.  
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1 – In vitro azoxymethane model for colon carcinogenesis 
 
1.1 – Introduction 
  
Colon cancer is one of the most common types of cancer in humans, so there is a 
need to improve colon cancer research and find ways to diagnose, prevent, and treat the 
disease. But the use of animal models always has its drawbacks, especially when it is used 
to evaluate potential dietary chemopreventive compounds. In chemoprevention and 
mechanistic studies, in addition to animal models, there has to be a complete cell culture 
study to screen for the compound or compounds that have higher potential for the effect 
that is desired. But, as cell culture is great for large scale screening of compounds, very 
often the effects do not hold up when used in animal models. In animal models, the 
compounds 1,2-dimethylhydrazine (DMH) and its derivative, azoxymethane (AOM), are 
the two most commonly used colon cancer chemical inducers. This model shares many 
similarities with sporadic colon cancer and is widely used to evaluate chemopreventive 
compounds [Suman, S., et al., 2012].  
 In the animal model, AOM is metabolized in the liver by CYP2E1 enzyme to 
methylazoxymethanol (MAM). This compound then circulates in the blood stream and 
reaches the colon where it is metabolized to the ultimate carcinogenic metabolite, the 
methyldiazonium ion. This metabolite is highly reactive and induces DNA damage in the 
cells, mainly O6-methylguanine (O6meG), giving rise to mutations in colon cells. O6-
methylguanine methyltransferase (MGMT) is the key enzyme for DNA repair and 
apoptotic removal in this model. O6meG is rapidly formed within 2 h of AOM 
administration in the rat colon. MGMT quickly repairs the lesion, being possible to see a 
quick depletion of the expression of this protein in a dose and time dependent manner. 
Apoptosis is only triggered when MGMT is no longer able to correct the lesion. But when 
even apoptotic removal is insufficient, O6meG quickly transforms in mispairs, leading to 
point mutations [Nyskohus, L.S., et al., 2013]. It has been shown that genes that are 
mutated in sporadic cases of colon carcinogenesis are also found mutated in the AOM-
induced colon carcinogenesis model. Some of these mutations alter key pathways 
involved in cell proliferation and apoptosis. These pathways include the WNT and MAPK 
pathways. APC is a protein involved in the WNT signaling pathway and it is involved in 
the regulation of free β-catenin. APC mutation is believed to be one of the first alterations 
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in colon carcinogenesis. With the AOM model, Apc mutations are rare (around 33% of 
tumors have this alteration), but a β-catenin mutation that has the same effect as the APC 
mutation in humans is induced in around 80% of AOM-induced tumors [Perse, M., et al., 
2011; Takahashi, M., et al., 2004]. Another mutation that is found in the AOM animal 
model is the Kras mutation. In this model, mutations in the Kras gene are point mutations 
most commonly observed in codon 12, promoting a G to A transition, which 
constitutively activates the MAPK signaling pathway. Kras mutations seem to be as 
frequent in the AOM model as in human carcinogenesis. This alteration has been 
observed more frequently, in humans and in the AOM model, in hyperplastic lesions, so 
it seems that this mutation is involved in early events of carcinogenesis [Perse, M., et al., 
2011; Takahashi, M., et al., 2004].  
 Animal models have been useful to explore the different features of colon 
carcinogenesis. But there are limitations in the use of animal models. Different models 
can give different results in the study of the effects of the same compound in colon 
carcinogenesis. So, in this study, we initiated a possible development of an in vitro model 
with the characteristics of the AOM-induced animal model for effective screening 
processes. We used the Caco-2 cell line, a colon cancer cell line with no alterations in the 
MAPK and WNT signaling pathways. Using AOM, we characterized the alterations 
induced by the carcinogen in our in vitro model and compared them to the AOM in vivo 
model, to ensure that the same modifications were being induced. 
  
1.2 – Material and methods 
 
1.2.1 – Reagents and antibodies 
N-Methyl-N-nitrosourea (MNU), O6-benzylguanine (BG), thiazolyl blue 
tetrazolium bromide (MTT), AOM, S9 liver fraction, Dulbecco’s modified Eagle medium 
(DMEM), penicillin/streptomycin, and trypsin solution were purchased from Sigma–
Aldrich (St. Louis, MO, USA). Fetal bovine serum (FBS) was purchased from Biochrom 
KG (Berlin, Germany). SYBR Gold (nucleic acid gel stain) was from Invitrogen 
Molecular Probes (Eugene, OR, USA). The protein quantification DC protein assay was 
purchased from Bio-Rad Laboratories (Hercules, CA, USA). Primary antibodies were 
purchased from the following sources: anti-actin was purchased from Sigma–Aldrich; 
anti-JNK, anti-phospho-JNK, anti-phosphoERK1/2, anti-K-Ras, anti-B-Raf, anti-MGMT, 
anti-MLH1, anti-β-catenin, and anti-histone H1 from Santa Cruz Biotechnology, Inc. 
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(Santa Cruz, CA, USA); and anti-p44/42 MAPK (ERK1/2), anti-phospho-Akt (ser473), 
and anti-Akt from Cell Signaling (Danvers, MA, USA. Peroxidase-conjugated goat anti-
mouse antibody and Immobilon Western blotting detection reagents were purchased from 
Santa Cruz Biotechnology (Santa Cruz, CA, USA) and Millipore (Billerica, MA, USA), 
respectively. All other reagents and chemicals used were of analytical grade. 
 
1.2.2 – Cell line and culture conditions 
Caco-2 cells, derived from human colon carcinoma, cells were maintained as 
monolayer cultures in DMEM supplemented with 10% FBS and antibiotics (100 U/mL 
penicillin and 100 mg/mL streptomycin), under an atmosphere of 5% CO2 at 37 ºC. Cells 
were seeded onto 6- (2 mL) or 12- (1 mL) well plates at a density of 0.1×106 cells/mL. 
Test compounds were added to culture medium to the desired concentration ensuring that 
the DMSO concentration did not exceed 0.5% (v/v); controls received vehicle only. 
To enhance the enzymatic biotransformation of AOM, a mixture of S9 from 
human liver and an exogenous NADPH-regenerating system was added to the medium at 
the same time of the procarcinogen (0.5% v/v S9 liver fraction, 1 mM NADP+, 5 mM 
glucose-6-phosphate, 0.4 U/mL glucose-6-phosphate dehydrogenase, and 3.3 mM 
magnesium chloride).  
 
1.2.3 – Assessment of cell viability/proliferation by MTT reduction test 
A MTT reduction assay was performed in order to evaluate the toxicity/increase 
proliferation of AOM in this colon cancer cell line. Cells were treated with different 
concentrations of AOM for 6, 24, 48 and 72 h, including 2 h incubation with MTT (final 
concentration 0.5 mg/mL). The formazan crystals were then dissolved in a solution of 
DMSO/ethanol (1:1). The number of viable cells in each well was estimated by the cell 
capacity to reduce MTT. The results were expressed as percentage relative to the control 
(cells without any test compound). 
 
1.2.4 – Nuclear condensation assay 
The effects of AOM (15 µM) treatment, with and without S9 liver fraction mixture, 
on induction of apoptosis in Caco-2 cells was assessed by nuclear condensation assay. 
The number of apoptotic cells was counted after 48 and 72 h as previously described 
[Xavier, C.P., et al., 2009]. Staurosporin (STS) at 0.5 µM was used as positive control. At 
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least 500 cells were counted and the number of apoptotic cells was divided by the total 
number cells counted to give the percentage of cell death.  
 
1.2.5 – Genotoxicity assay 
 The alkaline version of the single cell gel electrophoresis (comet) assay was used 
to evaluate DNA damage [Collins, A.R., 2004]. Caco-2 cells were incubated for different 
time points (1, 2, 4, and 6 h) at 37 ºC with AOM (5 and 15 µM), with and without S9 liver 
fraction mixture. Cells were collected by trypsinization and around 50,000 cells were 
centrifuged for 1 min at 5,000 rpm, ressuspended in low melting point agarose and spread 
onto agarose-coated slide using a cover slip. After 10 min at 4 ºC, the coverslips were 
removed and slides were placed in lysis solution (2.5 M NaCl, 100 mM Na2EDTA, 10 
mM Tris base, pH 10, plus 1% Triton X-100) for 1 h at 4 ºC. Slides were then placed in 
a horizontal electrophoresis chamber with electrophoresis solution (0.3 M NaOH, 1 mM 
Na2EDTA, pH > 13) for 40 min at 4 ºC for the DNA to unwind before electrophoresis for 
20 min at 0.8 V/cm and ∼300 mA. After electrophoresis, slides were washed twice with 
PBS and dried at room temperature (RT). For analysis of the comet images, slides were 
stained with SYBR Gold solution for 30 min at 4 ºC; after drying, the slides were analyzed 
using a fluorescence microscope and the Comet IV analysis system (Perceptive 
Instruments Ltd, Haverhill, UK) was used to calculate the parameter percentage of DNA 
in the tail. About 100 randomly selected cells were analyzed per sample. 
 
 1.2.6 – CoMeth assay 
The adapted version of the comet assay (CoMeth) was used to measure the 
potential of AOM to induce specifically the O6-methylguanine (O6meG) lesion [Ramos, 
A.A., et al., 2013]. Briefly, cells were pretreated with or without BG, 100 µM, for 2 h 
before treatment for 1, 24, 48 or 72 h of AOM (15 µM), with or without S9 liver fraction 
mixture, or MNU (used as positive control). Afterwards, the comet assay was continued 
as referred previously.  
 
1.2.7 – DCFH oxidative stress assay 
The capacity of DCA to induce reactive oxygen species was evaluated using the 
dichlorofluorescin (DCFH) oxidative stress assay. Briefly, culture medium was removed 
and cells were washed with PBS. Afterwards, cells were incubated with 2′,7′-
Dichlorofluorescein diacetate (DCF-DA) (100 µM) or DMSO (vehicle) for 30 min at 37 
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ºC. This solution was removed and cells were washed with PBS. Cells were then 
incubated with AOM (15 µM), with and without S9 liver fraction mixture, or tert-butyl 
hydroperoxide (200 µM), diluted in serum-free medium, for 30 min at 37 ºC. The 
compounds were removed and cells were lysed with a solution of 90% DMSO/10% PBS 
for 10 min at RT in the dark. Fluorescence was read at 520 nm upon excitation at 485 nm.  
 
1.2.8 – Western blot analysis 
Cells were incubated with AOM (15 µM) for 6, 24 and 48 h, with and without S9 
liver fraction mixture. For the pretreatment with the bile acids, bile acid treatment was 
done for 6 h prior to a 24 h incubation with AOM, with and without S9 liver fraction 
mixture. Total cell lysates were prepared to measure expression of different proteins. The 
cells were washed with PBS 1x and lysed for 5 min at 4 °C with ice-cold RIPA buffer 
(1% NP-40 in 150 mM NaCl, 50 mM Tris (pH 7.5), 2 mM EDTA) supplemented with 20 
mM NaF, 1 mM phenylmethylsulfonyl fluoride, 20 mM Na3VO4 and protease inhibitor 
cocktail (Roche, Mannheim, Germany). Protein concentration was quantified using the 
DC protein assay following the manufacturer’s instructions, and 20 µg/well was separated 
by 12% SDS–PAGE and transferred to polyvinylidene difluoride membranes. 
Membranes were blocked and incubated with primary antibody overnight. After washing, 
membranes were incubated with secondary antibody conjugated with IgG horseradish 
peroxidase for 1 h, and immunoreactive bands were detected using the Immobilon 
solutions (Millipore, Billerica, MA, USA) under a chemiluminescence detection system 
(Chemi Doc XRS; Bio-Rad Laboratories, Inc.). 
Band area intensity was quantified using the Quantity One software from Bio-
Rad. β-Actin was used as loading control. 
 
1.2.9 – Statistical analysis 
Statistical analyses were done using t-test, one-way or two-way analysis of 
variance using GraphPad Prism 4.0 software, when appropriate (San Diego, CA, USA). 
P values ≤0.05 were considered statistically significant. All results are presented as mean 
± SEM of at least three independent experiments. Images are representative of three 
independent experiments. 
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1.3 – Results and discussion 
 
 In this study, we searched for an in vitro model of the AOM-induced 
carcinogenesis, for easier screening purposes of chemopreventive compounds. To our 
knowledge, very few studies have used azoxymethane in in vitro models. IEC-6 intestinal 
cells are from rat small intestine epithelium and have been used in in vitro studies with 
AOM [Sasaki, T., et al., 2005; Sasaki, T., et al., 2006]. The authors used these cells to 
evaluate the potential of deoxycholic acid and linoleic acid to promote or inhibit AOM-
induced carcinogenic transformation, respectively. In these two studies, the authors found 
that, in both cases, the compounds inhibit IEC-6 transformation. For the effects of AOM, 
the authors used a 40-week incubation period, but then did not characterize fully the effect 
of the carcinogenic transformation and compare it to the in vivo model, specifically the 
signaling pathways that could be altered and induce this transformation. 
 Contrarily to the studies mentioned above, in this study, a human colon cancer 
cell line was used, Caco-2 cells, and the characterization of the effects of AOM in this 
cell line was assessed. The time points used were up to 72 h, and not 40 weeks as in the 
study by Sasaki, T., et al., to see if there are immediate effects of AOM in the cell line, 
as it has been shown that O6meG is rapidly formed within 2 h of AOM administration in 
the rat colon. The effect on cell proliferation was evaluated by the MTT assay (Figure 1). 
No differences were found with the different concentrations (from 0.05 to 5 µM) of the 
carcinogen at any of our time points (6, 24, 48 and 72 h). It is known that AOM has to be 
metabolized to methylazoxymethanol, and this is done through the CYP2E1 enzyme. It 
has been shown that Caco-2 cells express this enzyme and the enzyme is active [Lampen, 
A., et al., 1998], but, as in studies in cell lines that do not have active metabolizing 
enzymes, we used a liver S9 fraction to enhance the metabolization of AOM. Using 5 and 
15 µM of AOM for 24 and 48 h incubations, we detected a significant increase of 
proliferation with 15 µM of AOM at 48 h, with S9 mixture (Figure 2). So with this result 
it seems that the S9 liver fraction enhanced AOM metabolization and alterations occurred 
that increased slightly cell proliferation. This increase of proliferation could suggest an 
alteration in signaling pathways that regulate this process. 
 
Chapter 3                                                                           In vitro model of azoxymethane-induced damage 
 
71 
 
 
Figure 1 – The effect of different concentrations (0.05, 0.1, 0.5, 1 and 5 µM) of AOM on cell viability at 
6, 24, 48 and 72 h, in Caco-2 cells. Cell viability was measured by the MTT assay and results are the mean 
± SEM of at least 3 independent experiments. 
 
We found no significant decrease in proliferation, but to evaluate if the 
concentration of AOM used would be too cytotoxic, we evaluated the induction of cell 
death through nuclear condensation assay. AOM, at 15 µM, did not induce cell death in 
any of the conditions tested, when compared with respective control group (Figure 3). So, 
this far in the characterization of our model, AOM induces a slight, but significant, 
increase in cell proliferation after 48 h incubation and does not induce cell death in Caco-
2 cells. 
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Figure 2 – The effect of different 5 and 15 µM of AOM on cell viability at 24 and 48 h, in Caco-2 cells. 
Control experiment was done in normal medium while S9 experiment was done adding the mixture of S9 
liver fraction. Cell viability was measured by the MTT assay and results are the mean ± SEM of at least 3 
independent experiments. *P≤ 0.05, when compared with respective control was determined by one-way 
ANOVA followed by Newman-Keuls multiple comparison test. 
 
DNA damage is an important and initiating step in colon carcinogenesis and is a 
significant consequence of the production of reactive oxygen species (ROS) [Ramos, 
A.A., et al., 2011]. The metabolism of procarcinogens can induce production of ROS, 
and these, in turn, induce damage in cellular molecules, such as DNA. The potential of 
AOM metabolism to induce ROS and DNA damage was evaluated by the DCFH 
oxidative stress assay and comet assay, respectively. ROS formation was measured after 
30 min of incubation with AOM, although no effects were found on the production of 
ROS (Figure 4). A preliminary teste at 1 h incubation was also done to evaluate the 
necessity of a longer time point, but no effects were seen in these conditions as well (data 
not shown). 
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Figure 3 – Effects of 15 µM of AOM, with and without S9 liver fraction mixture, on apoptosis induction 
in Caco-2 cells. Apoptosis was measured by the nuclear condensation assay after 48 and 72 h incubation 
with the compound. Staurosporin (STS) at 0.5 µM was used as a positive control. Results are expressed as 
mean ± SEM of at least 3 independent experiments. ** P≤ 0.01, when compared with respective control, 
was determined by two-way ANOVA followed by Bonferroni post-tests. 
 
As we found no ROS production with AOM tretament, we further evaluated the 
effect of AOM to induce DNA damage (Figure 5). We found no induction of DNA 
damage induced by AOM in any of the conditions tested. Not many studies have shown 
AOM-induced DNA damage. In the study with the IEC-6 cell line, they found increased 
DNA damage with AOM treatment alone, but not in cells treated with AOM and DCA 
[Sasaki, T., et al., 2005]. In a study where the effect of beer drinking on colon 
carcinogenesis, they found an increase of DNA damage induced by AOM in isolated 
colonocytes, and this DNA damage was reduced with beer consumption [Nozawa, H., et 
al., 2004]. In the first study, AOM was given during 40 weeks, while in the second study 
16 h before animal sacrifice, the lack of results in our study could be due to a time issue, 
as we used short time periods (1, 2, 4 and 6 h). Studies with longer exposure times would 
help clarify this discrepancy.  
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Figure 4 – Effects of 30 min incubation of AOM (15 µM), with and without S9 liver fraction mixture, on 
the production of ROS. Results are expressed as mean ± SEM of at least 3 independent experiments. ROS 
production was measured by DCFH oxidative stress assay and tert-butyl hydroperoxide (200 µM) was used 
as postive control. *P≤ 0.05 when compared with control was determined by student’s t-test. 
 
It is known that AOM cause DNA adducts that lead to induction of O6meG [Fiala, 
E., 1975; Papanikolaou, A., et al., 1998], and as the standard comet assay gives 
information on strand break type damage, we used our new adaptation of the comet assay 
(CoMeth) to assess the induction of this type of lesion (Figure 6). With this assay, we 
found no induction of O6MeG with AOM with the tested conditions. The assay was 
functional as we found induction of this type of lesion with our positive control. So far in 
this study, it seems that, although we were able to induce a slight increase of proliferation 
with AOM, the other characteristics of the in vivo model have not been fulfilled. 
The O6MeG lesion gives rise to point mutations in key regulatory genes. It has 
been demonstrated that the most common genes altered by point mutations in the AOM-
induced in vivo models are Kras and β-catenin [Perse, M., et al., 2011]. With this in mind, 
and the fact that a slight increase in proliferation was found, the effect of AOM on the 
MAPK and WNT signaling was evaluated. No effects were found on KRAS and BRAF 
protein expression with any of the treatments (Figure 7). But, the downstream protein 
phospho-ERK was found slightly increased, although the values are not statistically 
significant with AOM treatment and S9 liver fraction mixture (Figure 8). This effect was 
found at 6 and 24 h incubation. So, it seems that the MAPK/ERK pathway is slightly 
activated, and could explain the slight increase in proliferation, although the activation is 
from 6 to 24 h incubation and the increase of proliferation is seen at 48 h incubation.  
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Figure 5 – Effects of AOM on DNA damage induction in Caco-2 cells using the comet assay. Cells were 
treated with 5 or 15 µM of AOM for 1, 2, 4, or 6 h of AOM, with and without S9 liver fraction mixture. 
Results are expressed as mean ± SEM of at least 3 independent experiments.  
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Figure 6 – Effects of AOM on O6-MeG-type DNA damage induction in Caco-2 cells using the adapted 
version of the comet assay. Cells were pretreated with or without BG, 100 µM, for 2 h before treatment for 
1, 24, 48 or 72 h of AOM, with and without S9 liver fraction mixture. MNU was used as a positive control. 
Results are expressed as mean ± SEM of at least 3 independent experiments. *P≤ 0.05 when compared with 
respective control was determined by one-way ANOVA followed by Newman-Keuls multiple comparison 
test. 
 
As the O6MeG lesion is corrected by the protein methylguanine methyltransferase 
(MGMT), or, if not repaired by this system, is corrected by the mismatch repair system, 
the expression of MGMT protein and MLH1 (intervenient in the mismatch repair system) 
was also evaluated. MLH1 expression was not significantly altered with the various 
treatments (Figure 9). On the other hand, AOM treatment with S9 mixture showed a 
tendency to increase MGMT expression at 24 h incubation. As MGMT is a suicide protein, 
it could be hypothesized that AOM induced O6MeG lesion, but most of the cells had the 
capacity to correct this lesion. Although we did not find evidence of AOM inducing 
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O6meG with our comet assay, it does seem that AOM induces a response that increases 
MGMT expression.  
   
 
Figure 7 – Effects of treatment with AOM (15 µM) for 6, 24, and 48 h on BRAF and KRAS protein 
expression in Caco-2 cells, using western blot. A representative blot is shown under the quantification. β-
actin was used as loading control. Values are mean ± SEM of at least three independent experiments. 
 
Deoxycholic acid, a secondary bile acid, is considered a promoter of colon 
carcinogenesis [Flynn, C., et al., 2007], while ursodeoxycholic acid is believed to be 
preventive of carcinogenesis. In the previous chapter, we showed the effects of DCA and 
UDCA on the expression of several proteins involved in DNA repair and cell signaling. 
With this in mind, we further investigated the possible effect of pretreatment with the bile 
acids on AOM effects on phospho-JNK, MLH1 and BRAF expression (Figure 10). We 
found no differences of expression with neither DCA nor UDCA on these proteins, 
although there is a slight decrease of BRAF and phospho-JNK expression with the bile 
acids and a slight increase of MLH1 expression. This slight increase in MLH1 was also 
seen with 6 h incubation of the bile acids alone (chapter 2).  
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Figure 8 – Effects of treatment with AOM (15 µM) for 6, 24, and 48 h on phospho-ERK and phospho-JNK 
protein expression in Caco-2 cells, using western blot. A representative blot is shown under the 
quantification. The total protein was used to normalize the values. Values are mean ± SEM of at least three 
independent experiments. *P ≤ 0.05 when compared to control was determined by student’s t-test.  
 
Another pathway that can be altered in in vivo AOM-induced tumorgenesis is the 
WNT pathway [Perse, M., et al., 2011]. The mutation in the Apc or β-catenin gene disrupt 
the regulation of β-catenin and this protein accumulates in the nucleus and acts as a 
transcription factor, regulating cellular processes, such as proliferation [White, B.D., et 
al., 2012]. We analyzed the expression of nuclear β-catenin with AOM treatment (Figure 
11). No increase in nuclear β-catenin was seen in Caco-2 cells with 24 h incubation of 
AOM. As β-catenin mutations usually appear in lesions with dysplastic features 
[Takahashi, M., et al., 2004], the time point of the assay is probably not sufficient to see 
alterations in the WNT pathway.  
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Figure 9 – Effects of treatment with AOM (15 µM) for 6, 24, and 48 h on MLH1 and MGMT protein 
expression in Caco-2 cells, using western blot. A representative blot is shown under the quantification. The 
total protein was used to normalize the values. Values are mean ± SEM of at least three independent 
experiments.  
 
In conclusion, with this in vitro model, we were able to induce an increase in 
proliferation, which is typical of carcinogenic cells. We found no effects on induction of 
DNA damage by AOM. Different AOM incubation times should be tested. We found a 
slight increase in phospho-ERK expression although not statistically significant. This 
slight increase can give us some information that this signaling pathway is being altered, 
but more studies need to be performed. No effects were seen with β-catenin nuclear 
translocation, but the time point could be too soon. With these preliminary results, it 
appears that our model can be inducing some genetic alterations that could be comparable 
with the alterations seen in the in vivo model, but further work is needed to improve and 
validate this model. 
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Figure10 – Effects of pretreatment with DCA or UDCA for 6 h prior to AOM (15 µM) treatment for 24 on 
BRAF, MLH1, and pJNK protein expression in Caco-2 cells, using western blot. The total protein was used 
to normalize the values. Values are mean ± SEM of at least three independent experiments. 
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Figure 11 – Effects of treatment with AOM (15 µM) for 24 h on nuclear β-catenin expression in Caco-2 
cells, using western blot. A representative blot is shown under the quantification. The total protein was used 
to normalize the values. Values are mean ± SEM of at least three independent experiments. 
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1 – Colon cancer chemoprevention by sage tea drinking: decreased 
DNA damage and cell proliferation 
 
1.1 – Introduction 
 
Colorectal cancer (CRC) is one of the most common cancers worldwide and one 
of the leading causes of death by cancer in developed countries. Diet, in particular high 
fat foods, has been found to be an important risk factor in the development of this 
malignancy [Padidar, S., et al., 2012; Tang, F.-Y., et al., 2012]. A diet rich in fruits and 
vegetables has been shown, on the other hand, to have preventive effects on colon cancer 
[Pan, M.H., et al., 2011]. In agreement with this, a variety of natural occurring plant 
compounds, such as phenolic acids, flavonoids, and carotenoids, have been found to 
prevent aberrant crypt foci formation, the precursor lesions of colon cancer [Mori, H., et 
al., 2004; Pan, M.H., et al., 2011]. Salvia officinalis (sage) is a native plant to southern 
Europe commonly used as a tea and condiment in Mediterranean countries that also has 
been attributed medicinal properties, antiseptic, anti-inflammatory and 
antihyperglycemic activities, due to the high content of biologically active compounds 
[Miura, K., et al., 2002; Topcu, G., 2006]. The water extract of Salvia officinalis, used in 
the present study, contained rosmarinic acid and luteolin-7-glucoside, which are the major 
phenolic compounds of the species, while 1,8-cineole, cis-thujone, trans-thujone, 
camphor and borneol are the major volatile compounds [Lima, C.F., et al., 2005]. 
Previous studies have shown antioxidant properties of Salvia officinalis (SO) extracts 
[Lima, C.F., et al., 2005; Lima, C.F., et al., 2006] and a recent study has shown 
chemopreventive effects of this extract in vitro by protection against oxidative DNA 
damage and stimulation of DNA repair [Ramos, A.A., et al., 2010a]. Also, a study from 
our lab has shown that SO inhibited cell proliferation in HCT15, a colon cancer-derived 
cell line [Xavier, C.P., et al., 2009]. 
Genomic instability is a common characteristic of cancer cells. A combination of 
induction of DNA damage, defective DNA repair systems, and failure to stop the cell 
cycle to correct DNA before it is passed on to the next generation of cells may be 
contributing factors [Lord, C.J., et al., 2012]. DNA damage is constantly being inflicted 
to cells and, when the repair capacity is overwhelmed, it becomes the underlying cause 
of mutations. Critically, mutations may occur in key genes that control apoptosis and cell 
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proliferation, giving these cells growth advantage, eventually leading to cancer 
[Peltomaki, P., 2001]. The formation of aberrant crypt foci (ACF) is the reflex of 
increased cell proliferation which may result from DNA damage and occurrence of 
mutations in the colon mucosa. Many studies use induced ACF in rodents to study the 
chemopreventive or carcinogenic potential of natural or synthetic compounds [Johnson, 
R.L., et al., 2013]. 
In the present study, we evaluated the potential effect of SO water extract (sage 
tea) as a chemopreventive agent against the initiation and/or promotion of colon cancer 
in vivo. The preventive mechanisms were further characterized at the level of drug 
metabolism, proliferative and inflammatory markers, as well as at the level of colonocyte 
DNA protection. It was also of our interest to study DNA protection of lymphocytes. 
These cells are more accessible than colonocytes and the possibility of their use as 
surrogate markers of effects at the colonocyte level is evaluated. 
 
1.2 – Material and methods 
 
1.2.1 – Animals 
Female Fischer 344 rats, 3 weeks-old, were obtained from Charles River 
Laboratories and kept in quarantine during 1 week. Throughout the whole experiment, 
the animals had free access to food, an AIN76-based rat chow, and water or S. officinalis 
water extract (13.3 g/l). SO water extract was routinely prepared as an infusion by pouring 
450 mL of boiling water onto 6 g of the dried plant material and allowing to steep for 5 
min [Lima, C.F., et al., 2005]. The composition of the extract has been published 
elsewhere [Lima, C.F., et al., 2005], and the major phenolic compounds are rosmarinic 
acid and luteolin-7-glucoside (Table 1). Animals were weighed once a week during the 
whole experiment and food and water/sage tea consumption was registered 3 times a week. 
The experiments were carried out according to the regulations of national authorities for 
handling laboratory animals (Veterinary General Directive Board, Ministry of 
Agriculture, Rural Development and Fishing) and European Community Council 
Directive 86/609/EEC. 
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Table 1 – Main compounds found in SO water extract [Lima, C.F., et al., 2005]. 
Component μg/mL 
Water  
Phenolic acids  
 Rosmarinic acid 362.0 
Flavonoids  
 Luteolin-7-glucoside 115.3 
 Other luteolin glycosides (3) 48.5 
Volatile components 4.8 
 1,8-cineole 0.9 
 cis-thujone  1.7 
 trans-thujone  0.3 
 Camphor 0.5 
 Borneol 0.7 
 Other (20) 0.7 
Unknown 2972.0 
 
1.2.2 – Experimental design 
Rats were divided into 6 groups (Figure 1A). Groups 2 (Sage (pre)) and 4 (Sage 
+ AOM) had access to SO water extract instead of water (Groups 1 and 3) during the first 
two weeks. These two groups were used to evaluate the effects of sage water extract on 
initiating steps of the carcinogenic process. Groups 5 (Sage (post)) and 6 (AOM + Sage) 
had access to sage water extract during the last four weeks of the experiment. These two 
groups were used to investigate the potential of this extract to affect post-initiating steps 
of CRC progression. At the second and third week, groups 3 (Water + AOM), 4, and 6 
received a s.c. injection of AOM (15 mg/kg) in saline (0.9%). The other three groups 
received an injection of the vehicle. Seven weeks later, the animals were sacrificed and 
the colons removed for ACF and immunohistochemistry. 
For colonocyte and lymphocyte isolation, as well as for assessment of liver 
parameters, four additional groups of rats (Figure 1B) were sacrificed a day after AOM 
injection. For lymphocyte isolation, blood from all animals was collected in 5% EDTA 
and followed to the isolation protocol. The colon was also removed and washed in HBSS 
buffer (NaCl, 8.0 g/L; KCl, 0.4 g/L; Na2HPO4.12H2O, 0.12 g/L; KH2PO4.3H2O, 0.078 
g/L; NaHCO3, 0.35 g/L; HEPES, 4.8 g/L) for colonocyte isolation. 
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Figure 1 – Experimental plan 1 (A). G1 – Water, G2 – Sage (pre), G3 – Water + AOM, G4 – Sage + AOM, 
G5 – Sage (post), G6 – AOM + Sage. Experimental plan 2 (B). G1 - Water, G2 - Sage, G3 - Water + AOM, 
G4 - Sage + AOM All rats were kept in quarantine for one week. AOM injections were given to groups 3, 
4, and 6 at weeks two and three. Saline injections were given to the other three groups. At the end of the 
seventh week, all animals were sacrificed by decapitation. 
 
1.2.3 – Identification and quantification of ACF  
The colons were washed with ice cold phosphate buffered saline (PBS), cut open 
longitudinally, fixed in 3% (w/v) paraformaldehyde for 24 hours and then stored in 
ethanol.  
For ACF identification and quantification, colons were stained with 0.05% (w/v) 
methylene blue in PBS for 5 minutes. ACF number and multiplicity (number of aberrant 
crypts in each ACF) were scored blindly using a light microscope.  
 
1.2.4 – Immunohistochemical analysis of ACF 
Four µm sections were cut, deparaffinised and rehydrated. Antigen retrieval was 
performed using 10 mM citrate buffer solution, pH 6.0 at 98 ºC for 20 min and 
endogenous peroxidase inactivation was performed using 0.3% hydrogen peroxide for 10 
min. Sections were incubated with a protein blocking solution for 10 min and then 
incubated with primary antibody: Ki67 (1:100), Abcam, Cambridge, UK and β-catenin 
(1:100), Santa Cruz Biotechnology, Heidelberg, Germany. Next, the sections were 
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incubated with Streptavidine Peroxidase for 10 min followed by development with 3,3′-
diamino-benzidine (DAB + substrate System) during 10 min. Immunohistochemistry was 
performed using the Streptavidin-biotin peroxidase complex system (UltraVision Large 
Volume Detection System Anti-Polyvalent, Horseradish Peroxidase, Lab Vision 
Corporation, Fremont, CA, USA). Counterstaining was performed with hematoxylin and 
slides were permanently mounted. Ki67 positive-stained cells were expressed as 
percentage of positive cells per total number of epithelial cells per crypt.  
 
1.2.5 – Microsomal fraction preparation for CYP2E1 evaluation  
To measure the activity and expression of CYP2E1, liver microsomal fractions 
were isolated by differential centrifugation as previously described elsewhere [Barbier, 
O., et al., 2000]. Aliquots were frozen in liquid nitrogen and stored at -80 ºC until further 
use. 
 
1.2.6 – Evaluation of CYP2E1 activity 
The activity of CYP2E1 can be measured spectrophotometrically by following, at 
480 nm, the conversion of p-nitrophenol (PNP) to 4-nitrocatechol, as described by Allis 
et al., 1994 [Allis, J.W., et al., 1994].  
 
1.2.7 – CYP2E1 protein expression 
Protein concentration was quantified using with the Bradford Reagent purchased 
from Sigma using bovine serum albumin as a standard and 40 µg/well was separated by 
12% SDS–PAGE and transferred to polyvinylidene difluoride membranes. A rabbit 
polyclonal antibody against CYP2E1 (StressGen, Ann Arbor, MI, USA) protein (1:5,000) 
was used overnight at 4 ºC and secondary antibody incubation was done with anti-rabbit 
antibody conjugated with IgG horseradish peroxidase. A chemiluminescence detection 
system (Chemi Doc XRS, Bio-Rad Laboratories, Inc, Hercules, CA, USA) and band area 
intensity was quantified using the Quantity One software (Bio-Rad). 
 
1.2.8 – Glutathione-S-transferase (GST) activity 
Glutathione-S-transferase (GST) activity was measured in liver homogenates and 
was determined by following the formation of glutathione (GSH) conjugate at 340 nm 
with 1-chloro-2,4-dinitrobenzene (CDNB) as previously described by our group [Lima, 
C.F., et al., 2005].  
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1.2.9 – Colonocyte isolation 
The colons were removed and washed with HBSS buffer and then with ice-cold 
incubation solution (glucose, 1 g/L; DTT, 1 mM; glutamic acid, 2.4 mM, dissolved in 
HBSS buffer). The colons were then cut open longitudinally and placed in 10 mL of 
incubation solution, with 2 mg of proteinase K and 1.5 mg of collagenase, for 10 min at 
37 ºC, stirring slightly and gassed with carbogen (95% O2 and 5% CO2). The obtained 
cell suspension was filtered with 70 µm filters to separate the colonocytes. Next, 50 µL 
of 5.88% CaCl2 was added for each 5 mL of cell suspension, following a centrifugation 
at 200 g for 10 min at 4 ºC. The pellet was ressuspended in culture medium and cells were 
counted and used to measure DNA damage by the comet assay. 
 
1.2.10 – Lymphocyte isolation 
For lymphocyte isolation, the blood collected in EDTA solution was diluted in an 
equal volume of PBS buffer. This volume was added to a tube containing Ficoll, also in 
equal proportion, following a centrifugation at 1,800 rpm for 18 min, 18 ºC. The 
lymphocyte layer was removed and transferred to another tube where PBS was added and 
another centrifugation was done at 1,800 rpm for 10 min, 18 ºC. The pellet was 
ressuspended in medium and cells were counted and used to measure DNA damage by 
the comet assay.  
 
1.2.11 – Evaluation of DNA damage by comet assay and in vitro oxidative 
damage induction 
The alkaline version of the single cell gel electrophoresis (comet) assay was used 
to evaluate DNA damage [Collins, A.R., 2004]. Briefly, 50,000 cells were centrifuged for 
1 min at 5,000 rpm, ressuspended in low melting point agarose and spread onto agarose-
coated slide using a cover slip. To study protection against AOM-induced DNA damage 
in colonocytes and lymphocytes, the standard comet assay was used. To study protection 
against in vitro H2O2-induced DNA damage, colonocytes from sage or water drinking 
animals were used. After spreading these colonocytes on the slides, the slides were placed 
in different concentrations of H2O2 solution (25, 50, or 100 µM) or PBS (control), on ice 
for 5 min. After 5 min at 4 ºC, the cover slip was removed and the slides were placed in 
lysis buffer (NaCl, 2.5 M; Na2EDTA, 100 mM; Tris, 10 mM, pH 10) plus 1% Triton X-
100 for 1 h at 4 ºC. Then, the slides were left in electrophoresis buffer (NaOH, 300 mM; 
Na2EDTA, 1 mM, pH >13) for 40 min at 4 ºC. The electrophoresis was run for 20 min at 
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4 ºC, 21 V (0.8 V/cm) and 300 mA. After the electrophoresis, the slides were placed in 
neutralization buffer (Tris Base, 0.4 M, pH 7.4) for 15 min, washed with water and 
dehydrated with ethanol. To each slide, 20 µL of ethidium bromide was added and 100 
cells were counted under a fluorescent microscope and quantified by visual scoring and 
using Comet 4 image analysis system (Perceptive Instruments).  
 
1.2.12 – Statistical analysis 
Statistical significances were determined using Two-way ANOVA, followed by 
Bonferroni post-test for the effects of sage tea on protection against oxidative DNA 
damage, and Student’s t-test for all other data. Data was expressed as means ± SEM. p 
values ≤ 0.05 were considered statistically significant. 
 
1.3 – Results and discussion 
 
 Diet is an important factor in colon carcinogenesis. It has been shown that fat and 
red meat can promote tumorigenesis. However, diet can also have a beneficial effect on 
colon cancer [Ramos, A.A., et al., 2010b] and, in order to prevent this malignancy, dietary 
strategies to inhibit the formation or delay the progression of tumors are needed. In the 
present study, the chemopreventive potential of the water extract of sage, a plant with 
antioxidant properties [Lima, C.F., et al., 2005; Lima, C.F., et al., 2007b] and that has 
been shown to have in vitro ability to prevent DNA damage [Ramos, A.A., et al., 2010b], 
was studied against ACF formation in the AOM-induced colon carcinogenesis model. As 
our group has various studies demonstrating the in vitro potential of this extract, the 
objective in this study was to test whether the in vitro effects could also be present in vivo 
and correspond to a cancer preventive effect. We used the water extract and not an 
isolated compound of the extract to give emphasis a dietary strategies with whole 
compounds, of easy access, and to study the food, in this case a tea, as a complex mixture. 
Treatment with sage tea before exposure to the carcinogen (AOM injection) significantly 
decreased the number of ACF formed, indicating a chemopreventive effect of this extract 
on the initiation phase of the carcinogenic process in the colon (Figure 2A). The lack of 
effect of the extract when given after carcinogen injection (Figure 2A) and on crypt 
multiplicity (average number of aberrant crypts in each focus) (Figure 2B) indicates that 
after mutations set in, the herbal tea does not affect molecular mechanisms involved in 
promotional phases, at least not this early in the process. More studies with tumors would 
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be necessary to evaluate the potential of the herbal tea in advanced stages of 
carcinogenesis. Genetic animal models are now used to obtain important information on 
familial and sporadic colon carcinogenesis, but the AOM-induced model has been very 
useful in explaining the molecular mechanisms involved in sporadic CRC due to the 
similarities in the pathophysiology of the tumors with human colon tumors [Johnson, R.L., 
et al., 2013].  
 
 
Figure 13 – Effect of sage drinking in AOM-induced ACF formation and multiplicity. A – Average number 
of ACF found in the whole colon after methylene blue staining. B – Average number of aberrant crypt per 
foci (multiplicity) per crypt in the colon. The results are expressed as mean ± SEM for n=6. * P<0.05 when 
compared with water control. 
 
Effects of our herbal tea on initiation may reflect decreased AOM toxicity due to 
(1) decreased bioactivation through CYP2E1, (2) increased excretion through GST 
induction, (3) DNA damage protection, and/or (4) effects on cell proliferation. Beneficial 
effects of other plant foods have been found, for example, black tea and wine extracts, 
but not green tea, to protect against AOM-induced colon carcinogenesis in rats [Caderni, 
G., et al., 2000] and theaflavin-2, a major compound found in black tea extract was shown 
to induce apoptosis in human colon cell lines [Gosslau, A., et al., 2011]. In a study by 
Andersson et al., 2008 [Andersson, D., et al., 2008], ursolic acid, a pentacyclic 
triterpenoid also present in SO, was found to reduce the number of large ACF when given 
orally to rats during the initiation phase but not during the promotion/progression phase, 
results that are in agreement with our present study. Also, a study from our lab 
demonstrated that ursolic acid protects colon cells against DNA damage [Ramos, A.A., 
et al., 2010c]. 
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One of the possible mechanisms behind sage tea chemoprevention may be the 
modulation of enzymes involved in AOM metabolism. CYP2E1 enzyme is involved in 
the activation of AOM in vivo [Sohn, O.S., et al., 2001], suggesting that agents that 
modify this enzyme’s activity or expression levels may either promote or inhibit CRC 
through effects on formation of carcinogenic AOM derivatives. Based on this, effects of 
sage treatment on liver CYP2E1 activity and expression was evaluated, but no effects 
were found (Figure 3). A decrease of CYP2E1 activity with AOM injection was found, 
but this decrease was only significant in the water drinking group (Figure 3A). As 
demonstrated for other drugs, a decrease in CYP2E1 activity after a few hours (12-24 h) 
of AOM administration may indicate increased AOM metabolism and CYP2E1 
inactivation due to the high amount of free radicals produced [Lima, C.F., et al., 2007a; 
Weber, L.W., et al., 2003; Zhukov, A., et al., 1999]. Modulation of GST, a phase II 
enzyme, can increase carcinogen elimination before damage is done. In this study, and 
contrarily to what happened previously with mice [Lima, C.F., et al., 2005], no effects on 
GST activity in any of the treatment groups were found (data not shown). Altogether, 
these results indicate that the preventive effect of sage tea on ACF formation was not due 
to decrease in AOM bioactivation or increase of AOM elimination.  
 
 
Figure 3 – Effect of sage drinking (14 days) and/or AOM injection on CYP2E1 activity (A) and levels (B) 
measured in the microsomal fraction isolated from rat liver. CYP2E1 activity is expressed as nmol.min -
1.mg protein and protein levels expressed as percentage of water control group. The results are expressed 
as mean ± SEM for n=4. * P<0.05 when compared with water control. 
 
The most important initiating factor in carcinogenesis is the occurrence of DNA 
damage and mutations. It is known that dietary mutagens and oxidative stress may lead 
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to DNA damage. Dietary mutagens may be present in foods through fungal contamination 
or methods of preservation and cooking. One example of food mutagens are the 
heterocyclic amines 2-amino-1-methyl-6-phenylimidazol[4,5-b]pyridine (PhIP) and 2-
amino-3-methylimidazol[4,5-f]quinoline (IQ), which are produced from cooked protein-
rich foods such as meat and fish. The mutagenicity of these heterocyclic amines is DNA 
damage caused by induction of an inflammatory response [Ferguson, L.R., et al., 2008]. 
In our study, after bioactivation of AOM in the liver, methylazoxymethane (MAM) is 
transported to other organs where it will be further converted and finally, especially in 
the colon, induces DNA damage, suggesting that protection against DNA damage at the 
colonocyte level may be a relevant mechanism of chemoprevention. 
Therefore, the effect of in vivo SO treatment on protection against in vitro H2O2-
induced DNA damage in isolated colonocytes was investigated. Treatment with SO 
significantly decreased in vitro H2O2-induced DNA damage to colonocytes when 
compared with control (Figure 4), which is in agreement with our previous in vitro results 
[Lima, C.F., et al., 2007b; Ramos, A.A., et al., 2010b]. AOM-induced DNA damage to 
colonocytes was also evaluated. AOM was found to induce DNA damage detected by the 
comet assay, while SO treatment before AOM injection decreased DNA damage (Figure 
5A). In a study by Dolara et al., a protective effect of DNA damage in colonocytes was 
also found using wine polyphenols [Dolara, P., et al., 2005]. In the present study, the 
same protective effect of SO against AOM-induced DNA damage was found in 
lymphocytes isolated from the same animals (Figure 5B). This effect, as far as we know, 
has not been demonstrated in the literature and can be of great importance to further imply 
lymphocytes as surrogate markers in these kinds of studies. The protective effects of SO 
may be due, at least in part, to an increase in protection against DNA damage, which 
seems to be a global effect and not just localized in the colon, and may be the key to 
chemoprevention of colon cancer. Protection against DNA damage is not only beneficial 
for cancer prevention, but also for other diseases and the overall health of the individual.  
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Figure 4 – Effect of 2 week SO treatment in vivo on H2O2-induced DNA damage in isolated rat colonocytes. 
DNA damage analyzed by the Comet assay. Mean ± SEM (n=3). Statistical significances were determined 
using a two-way ANOVA followed by Bonferroni’s multiple comparison test. * P<0.05. 
 
It is also known that there is a link between chronic inflammation, proliferation 
and CRC [Hull, M., 2008; Itzkowitz, S.H., 2006; Terzic, J., et al., 2010]. The impact of 
SO on proliferation was evaluated in colon tissue, by Ki67 immunohistochemical staining 
of the colon mucosa. AOM increased the overall number of proliferating cells of the 
normal mucosa, but in animals treated with SO, this increase was significantly less 
pronounced (Figure 6A). The number of proliferative cells was naturally also higher in 
ACF when compared with the respective normal tissue (Figure 6B). Sage treatment was 
able to reduce the number of proliferating cells in the normal tissue, possibly as an effect 
of sage on different signalling pathways that regulate proliferation. A study from our lab 
showed that SO inhibits cell proliferation and inhibits the MAPK/ERK pathway in the 
KRAS mutated HCT15 cell line [Xavier, C.P., et al., 2009]. With this study, we add that 
SO also reduces cell proliferation in vivo. 
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Figure 5 – Effect of 2 week SO treatment and/or AOM injection on DNA damage on colonocytes (A) and 
lymphocytes (B) measured by the comet assay. DNA damage expressed as percentage of DNA in tail. The 
results are expressed as mean ± SEM for n=4. * P<0.05 when compared with water control, # P<0.05 when 
compared with Water + AOM group, ** P<0.01 when compared with water control, ### P<0.001 when 
compared with Water + AOM group. 
 
The WNT signalling pathway is important in the regulation of cell proliferation in 
the colon crypt [Pinto, D., et al., 2005], and AOM may cause mutations in β-catenin, an 
intervenient in this pathway [Takahashi, M., et al., 2004]. In the present study, no β-
catenin translocation to the nucleus was found in normal tissue or in ACF and APC 
expression was the same in all groups (data not shown). AOM may not have caused 
alterations in β-catenin possibly due to the short duration of the study relative to the time 
these mutagenic lesions need to be expressed. So, SO chemoprevention appears to be, 
apart from DNA protection from damage, also due to regulation of proliferation but does 
not appear to be in the regulation of WNT signalling pathway [Takahashi, M., et al., 2000; 
Takahashi, M., et al., 2004]. The MAPK/ERK pathway is usually also altered in this 
AOM-induced model. As it was referred before, SO has shown to inhibit this pathway in 
HCT15 cell line. As the WNT pathway was not altered, we could assume that sage tea is 
acting on the MAPK/ERK pathway. Studies in the activation of this pathway would 
answer this question.  
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Figure 6 – Proliferating cells in normal colon crypts of rats from water, Sage (pre), Sage (post), water + 
AOM and Sage + AOM groups (A) and ACF from water + AOM and Sage + AOM groups (B) assayed by 
Ki67 stained cells. Representative image of Water group (C) and Water + AOM group (D). Results are 
expressed as percentage of Ki67 stained cells per total number of cells in a crypt ± SEM for n = 4. *** = 
P<0.001 when compared with water group, ## = P<0.01when compared with Sage (pre) group, § = P<0.05, 
‡ = P<0.05 when compared with Water + AOM group of normal tissue, † = P<0.05 when compared with 
Sage + AOM group of normal tissue. 
 
In conclusion, treatment with sage water extract (herbal tea) showed a 
chemopreventive effect against AOM-induced preneoplastic lesions of colon cancer 
(Figure 9). An effect on colonocytes was demonstrated as SO treatment in vivo confers 
DNA protection against AOM- and H2O2-induced DNA damage. The protective effect of 
SO against DNA damage induced by AOM was also observed in lymphocytes. In 
addition, sage treatment significantly lowered the increased expression of Ki67, a marker 
of the overall proliferation rate in the colon. No evidence was found that sage treatment 
affected AOM metabolism in the liver or inflammation. This study showed that the 
consumption of Salvia officinalis tea may contribute to prevention of colon cancer, and 
mechanisms of protection against DNA damage and modulation of cell proliferation are 
involved. Plant foods and beverages, such as Salvia officinalis tea, have shown great 
potential and they should be considered as possible chemopreventive agents in dietary 
strategies against colon cancer. This herbal extract could ameliorate the overall health of 
the individual, not just against cancer initiation, but also diseases associated with DNA 
damage.  
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Figure 7 – Overview of the relevant results obtained in this study. Possible mode of action of Salvia 
officinalis colon cancer chemoprevention.  
 
2 – Impact of nutrition on DNA damage in rats 
 
2.1 – Introduction 
 
Colorectal cancer (CRC) is known to be caused by the accumulation of genetic 
and epigenetic alterations. Mutations and/or gene silencing may affect the expression or 
state of activation of key proteins involved in control of important cellular processes, such 
as cell proliferation, apoptosis, or repair of DNA damage [Arends, M.J., 2013]. Exposure 
to exogenous and endogenous agents results in an accumulation of DNA damage over 
time, and if not repaired, DNA damage contributes to carcinogenesis. Cells have a variety 
of DNA repair pathways to overcome the possible deleterious effects of DNA damage. 
Base excision repair (BER) is one of the major pathways involved in the repair of 
alkylation and oxidation DNA damage, repairing apurinic/apyrimidinic (AP) sites, DNA 
single-strand breaks and different types of base modifications [Maynard, S., et al., 2009]. 
Briefly, this pathway involves a recognition and excision step by glycosylases (for 
example, 8-oxoguanine glycosylase (OGG1) recognizes oxidized bases, while 
methylpurine-DNA glycosylase (MPG) recognizes alkylated bases), generating an AP 
site. This AP site is cleaved by an AP endonuclease, human AP endonuclease (APE1), 
generating a 3´OH and 5´deoxyribose phosphate terminus. Finally, DNA polymerase fills 
the nucleotide gap and a DNA ligase seals the nick on the DNA strand [Maynard, S., et 
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al., 2009]. The mismatch repair (MMR) system mainly corrects base to base mispairs 
which are caused by errors of the DNA polymerase. The recognition of these mispairs 
initiates a process that ends with the excision of the mispair and resynthesis of the DNA 
strand. Among the proteins important in this process, MSH2 and MLH1 are also found to 
be altered in CRC tumors [Lord, C.J., et al., 2012]. 
It has been demonstrated that CRC risk is strongly associated with diet. Dietary 
habits can help prevent or promote this disease [Nystrom, M., et al., 2009]. For example, 
western-type diet is thought to contribute to the development of colorectal cancer, while 
diets that are rich in fruits and vegetables have been found to be beneficial in the 
prevention carcinogenesis. Bile acids are considered as carcinogens in a variety of 
gastrointestinal cancers, including CRC. One of the effects of high bile acid exposure on 
cells is the DNA damage induced by reactive oxygen species (ROS) [Barrasa, J.I., et al., 
2013]. An increase of bile acid exposure increases ROS, which can increase DNA damage 
and consequently lead to mutations [Bernstein, H., et al., 2009]. On the other hand, 
phytochemicals, found in fruits and vegetables, can inhibit, delay and/or reverse 
carcinogenesis. (-)-Epigallocatechin-3-gallate (EGCG) is a catechin found in green tea 
and has been extensively used in chemopreventive studies in vivo and in vitro. EGCG 
was found to reactivate the expression of silenced genes by downregulation of DNA 
methyltransferases (DNMT) and histone deacetylases (HDAC) activity in human skin 
cancer cell lines [Nandakumar, V., et al., 2011]. Also, it has been found to suppress ACF 
formation when combined with sulindac and reduced the cytotoxicity induced by H2O2 
and increase levels of enzymes related to oxidative stress in HepG2 cells [Lambert, J.D., 
et al., 2010; Murakami, C., et al., 2002; Ohishi, T., et al., 2002]. Ursolic acid (UA) is a 
triterpenoid found in some fruits and herbs, with anti-cancer and anti-inflammatory 
properties. Previous work done in our lab has demonstrated various properties of UA, 
such as anticancer potential by induction of cell death in CRC cell lines and in vivo 
[Xavier, C.P., et al., 2013] and protection from oxidative damage and increase of DNA 
repair activity [Ramos, A.A., et al., 2010c]. In another study, UA was found to have 
inhibitory effects on the formation of pre-neoplastic lesions of CRC, demonstrating a 
chemopreventive effect [Andersson, D., et al., 2008]. 
The aim of our study was to evaluate the effect of diet on DNA damage and DNA 
repair systems in vivo. The potential chemopreventive effect of two natural compounds, 
UA and EGCG, was evaluated in lymphocytes and colonocytes and diet induced effects 
on in vivo protection from DNA damage and induction of repair. Also, the carcinogenic 
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potential of the bile acid, deoxycholic acid (DCA), was evaluated by induction of DNA 
damage and modulation of DNA repair systems. Blood samples are always easier to 
collect than colon samples, so another aim of this study was to evaluate the potential of 
lymphocytes to be surrogate markers of effects in colonocytes.  
 
2.2 – Material and methods 
 
2.2.1 – Animals 
Male Fischer 344 rats, 3 weeks-old, were obtained from Charles River 
Laboratories and kept in quarantine during 1 week. Throughout the whole experiment, 
animals had free access to food, an AIN76-based rat chow, and water. The experiments 
were carried out according to the regulations of national authorities for handling 
laboratory animals (Veterinary General Directive Board, Ministry of Agriculture, Rural 
Development and Fishing) and European Community Council Directive 86/609/EEC. 
 
2.2.2 – Experimental design 
Rats were divided into 5 groups (Figure 8). Natural compounds were given to the 
animals, using chocolate as the administration vehicle, during two weeks. The first group 
was control group, the second group was administered UA (50 mg/kg rat), third group 
received DCA (100 mg/kg rat), while the forth group received a combination of UA and 
DCA. The last group was administered EGCG (40 mg/kg rat). During this experiment, 
animals were weighted once a week and treatment did not alter significantly the average 
weight between groups (Figure 9). After treatment, the animals were sacrificed and the 
colons removed for colonocyte isolation.  
Blood was collected in 5% EDTA from all animals for lymphocyte isolation 
animals and followed to the isolation protocol.  
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Figure 8 – Experimental plan. Fischer 344 male rats were given different compounds every day during 2 
weeks. Control group received vehicle only, UA group was administered ursolic acid (50 mg/kg rat), DCA 
group received deoxycholic acid (100 mg/kg rat), UA + DCA received a combination of ursolic acid and 
deoxycholic acid, and finally the EGCG group was administered (-)-epigallocatechin-3-gallate (40 mg/kg 
rat). At the end of the two weeks, all animals were sacrificed by decapitation. 
 
 
Figure 9 – The average weight (g) of the animals in each group. There seems to be no difference between 
the treatments on the growth of the animals. 
 
2.2.3 – Colonocyte isolation 
The colon was removed and washed in HBSS buffer (NaCl, 8.0 g/L; KCl, 0.4 g/L; 
Na2HPO4.12H2O, 0.12 g/L; KH2PO4.3H2O, 0.078 g/L; NaHCO3, 0.35 g/L; HEPES, 4.8 
g/L) and with ice-cold incubation solution (glucose, 1 g/L; dithiothreitol (DTT), 1 mM; 
glutamic acid, 2.4 mM, dissolved in HBSS buffer). The colons were then cut open 
longitudinally and placed in 10 ml of incubation solution, with 2 mg of proteinase K and 
1.5 mg of collagenase, for 10 min at 37 ºC, stirring slightly and gassed with carbogen 
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(95% O2 and 5% CO2). The obtained cell suspension was filtered with 70 µm filters to 
separate the colonocytes. Next, 50 μL of 5.88% CaCl were added for each 5 mL of cell 
suspension, followed by a centrifugation at 200 g for 10 min at 4 ºC. The pellet was 
ressuspended in medium and cells were counted and used in the comet assay and western 
blot. 
 
2.2.4 – Lymphocyte isolation 
For lymphocyte isolation, the blood collected in a 5% EDTA solution was diluted 
in equal volume of PBS buffer. This volume was added to a tube containing Ficoll, also 
in equal proportion and centrifuged at 1,800 rpm for 18 min, 18 ºC. The lymphocyte layer 
was removed and transferred to another tube where PBS was added and another 
centrifugation was done at 1,800 rpm for 10 min, 18 ºC. The pellet was ressuspended in 
medium and cells were counted and used in the comet assay and western blot. 
 
2.2.5 – Evaluation of DNA damage by comet assay and in vitro 
oxidative/alkylating damage induction 
The alkaline version of the single cell gel electrophoresis (comet) assay was used 
to evaluate DNA damage in colonocytes and lymphocytes [Collins, A.R., 2004]. Briefly, 
15,000 cells were centrifuged for 1 min at 5,000 rpm, ressuspended in low melting point 
agarose and spread onto agarose-coated slide. To measure basal DNA damage, slides 
were placed in lysis buffer (NaCl, 2.5 M; Na2EDTA, 100 mM; Tris, 10 mM, pH 10) plus 
1% Triton X-100 for at least 1 h at 4 ºC. Then, these were washed in PBS and then in 
buffer (40 mM HEPES, 0.1 M KCl, 0.5 mM EDTA, 0.2 mg/mL bovine serum albumin 
(BSA), pH 8) before treatment with formamidopyrimidine DNA glycosylase (FPG) for 
20 min, 37 ºC. Afterwards, the slides were placed in electrophoresis buffer (NaOH, 300 
mM; Na2EDTA, 1 mM, pH >13) for 40 min at 4 ºC. The electrophoresis was run for 20 
min at 4 ºC, 21 V (0.8 V/cm) and 300 mA. After the electrophoresis, the slides were 
washed with water and dehydrated with ethanol.  
To measure prevention against oxidative and alkylating damage, cells were 
exposed to H2O2 (100 µM) or methyl methanesulfonate (MMS) (100 µM) for 5, on ice, 
and 15 min, at 37 ºC, respectively. Afterwards, the cells were centrifuged for 1 min at 
5,000 rpm, ressuspended in low melting point agarose and spread onto agarose-coated 
slides, and followed the same protocol as described previously. For analysis of the comet 
images, slides were stained with SYBR Gold solution for 30 min at 4 ºC; after drying, 
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slides were analysed using a fluorescence microscope, and a Comet 4 analysis system 
(Perceptive software) was used to calculate the parameter percent tail intensity. Generally, 
100 randomly selected cells were analysed per sample. 
 
2.2.6 – Evaluation of expression of DNA damage-related proteins by western 
blot 
MPG, APE1, and OGG1 expression was monitored by Western blotting in 
lymphocytes and colonocytes. Protein concentration was measured with the DC protein 
assay following manufacture instructions, and 20 μg/well was separated on 12% SDS-
PAGE and transferred to polyvinylidene fluoride membranes. Membranes were blocked 
and incubated with the monoclonal anti-MPG (Abcam, Cambridge, UK), anti-APE1 
(Abcam, Cambridge, UK) and anti-OGG1 (Abcam, Cambridge, UK). Immunoreactive 
bands were acquired using the Chemidoc camera (BioRad), and band area intensity was 
quantified by Quantity One software (BioRad). The results were expressed as percentage 
of control group. 
 
2.2.7 – Statistical analysis 
Data are expressed as means ± SEM. Statistical significances were determined using a 
Student’s t-test and one-away analysis of variance using GraphPad Prism 5.0 software. P 
values ≤ 0.05 were considered statistically significant. 
 
2.3 – Results and discussion 
 
Colon cancer is a major contributor to cancer–related morbidity, and cancer 
chemoprevention is becoming an important concept to implement through the use of 
nontoxic agents, specifically dietary sources, as a proper strategy for disease control. 
Natural products are now known to be promising agents in cancer prevention and therapy. 
Several reviews have compiled information on various dietary constituents and their 
possible contribution in the modulation of cancer development [Duthie, S.J., 2011; 
Lofano, K., et al., 2013; Nolfo, F., et al., 2013]. Recent studies from our group have also 
demonstrated the potential of natural compounds to protect against DNA damage and 
induction of DNA repair [Ramos, A.A., et al., 2010a; Ramos, A.A., et al., 2013; Ramos, 
A.A., et al., 2012; Ramos, A.A., et al., 2010c]. This study demonstrated that UA and 
EGCG in the diet protect colonocytes and lymphocytes from endogenous DNA damage 
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both in vivo and in vitro from MMS exposure. Bile acids are associated with high fat diets 
and DCA has been associated with increased risk of CRC [Barrasa, J.I., et al., 2013; 
Bernstein, H., et al., 2009]. We used DCA, also added in the diet, to evaluate the effect 
on DNA damage and DNA repair protein expression. 
Unlike most studies that test DNA protection by dietary compounds in animals 
exposed to a genotoxic agent, in this study we used healthy individuals to evaluate the 
potential for cancer prevention by reduction of DNA damage. Endogenous DNA damage 
(strand breaks and FPG sites) in colonocytes and lymphocytes were evaluated by comet 
assay without and with FPG enzyme, respectively (Figure 10). Both cell types have more 
strand breaks than DNA damage recognized by FPG enzyme (FPG sites). Comparing 
endogenous DNA damage between colonocytes and lymphocytes, we found that the level 
of strand breaks are similar between the two cell types, while colonocytes present a 
tendency for higher levels of DNA damage recognized by FPG. This is in agreement with 
other studies that find higher levels of damage in colon tissue when compared with 
lymphocytes [Kager, N., et al., 2010].  
 
 
Figure 10 – Endogenous DNA damage in colonocytes and lymphocytes. DNA damage was measured by 
the comet assay. Results are expressed as percentage of DNA in tail and represent the means of at least 3 
independent experiments. *P ≤ 0.05, ** P≤ 0.01 when compared with strand breaks was determined by 
student’s t-test.  
 
Oxidative DNA damage has been associated with being the cause of degenerative 
diseases and cancer. Several types of damaged bases result from ROS attack on DNA, 
many with mutagenic potential. 8-oxoguanine is a biomarker of oxidative stress and is 
believed to participate in carcinogenesis, possibly through G to T transversions through 
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mispairing during replication [Tudek, B., et al., 2012] when it is efficiently repaired by 
the base excision repair system. Colonocytes treated with H2O2 showed an increase of 
strand breaks relative to endogenous strand breaks (Figure 11A). This increase was 
around 47% in comparison to respective control. H2O2 did not induced FPG sites in 
colonocytes. In lymphocytes, H2O2 (in the same concentration used for colonocytes) 
induced a high level of strand breaks (Figure 11B), most of the comets observed had more 
than 70% of the DNA in the tail of the comet. Therefore, lymphocytes showed more 
susceptibility to H2O2–induced DNA damage than colonocytes. The compounds tested in 
this study reduced the overall endogenous DNA damage (Figure 12A and 13A). In 
lymphocytes (Figure 13A), these natural compounds were found to reduce endogenous 
strand breaks. In a study by Brevik et al., intake of a diet rich in phytochemicals by healthy 
human individuals during a total of eight weeks decreased significantly the levels of 
endogenous strand breaks in lymphocytes [Brevik, A., et al., 2011]. On the other hand, 
reduction of DNA damage recognized by FPG, oxidative DNA damage, was seen by 
ursolic acid and EGCG in colonocytes (Figure 12A). The differences between the results 
in colonocytes and lymphocytes could be explained by the metabolization and absorption 
of the compounds.  
 
 
Figure 11 – Induced DNA damage in colonocytes (A) and lymphocytes (B): endogenous, H2O2, and MMS-
induced DNA damage. H2O2 treatment was done 5 min on ice, while MMS was 15min at 37 ºC. DNA 
damage was measured by the comet assay. Results are expressed as percentage of DNA in tail. *P ≤ 0.05, 
** P≤ 0.01, ***P ≤ 0.005 when compared with endogenous DNA damage was determined by student’s t-
test. 
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Alkylating DNA damage can result from exogenous, such as diet and environment, 
or endogenous (metabolism of enteric bacteria) sources. Alkylating damage include N-
alkylating adducts (N7-methylguanine, N3-methyladenine, and N3-methylguanine) and O-
alkylating adducts. N-alkylating adducts are more abundant but are cytotoxic and less 
mutagenic than O-alkylating adducts. In our study, we used methyl methanesulfonate, 
which induces N7-methylguanine and N3-methyladenine, causing base mispairs that are 
recognized and repaired by base excision repair [Lundin, C., et al., 2005; Ramos, A.A., 
et al., 2013]. Since, FPG can also recognize alkylation damage, such as N7-methylguanine, 
it was used to detect MMS-induced DNA damage. We found that MMS increased 
significantly the amount of strand breaks and FPG sites when compared with the control 
in colonocytes (Figure 11A). We found no effects of our natural compounds on MMS-
induced DNA damage in lymphocytes (Figure 13B), but in colonocytes (Figure 12B) UA 
significantly decreased strand breaks and FPG sites, while EGCG only showed a slight 
tendency to decrease FPG sites induced by MMS. To our knowledge, few studies have 
studied the effect of UA on alkylating DNA damage. In a study with rats, it was found 
that administration of UA before treatment with an alkylating carcinogen, azoxymethane, 
reduced the number of preneoplastic lesions when compared with control group 
[Andersson, D., et al., 2008]. UA was effective in reducing the oxidative stress mediated 
changes in liver of rats, showing chemopreventive potential in the liver [Gayathri, R., et 
al., 2009]. Ramos et al. demonstrated that ursolic acid protects DNA from oxidative 
damage and increases repair activity in vitro [Ramos, A.A., et al., 2010c]. EGCG is a 
flavonoid polyphenol found in green tea. It has been found to possess a variety of 
protective activities against cancer, such as inhibition of growth factor signaling and gene 
transcription and induction of tumor suppressors, but also the antioxidant activity of 
EGCG has been proposed as a potential anti-cancer mechanism [Lambert, J.D., et al., 
2010]. So, UA is able to decrease endogenous DNA damage and also decrease DNA 
damage induced by alkylating agents, in this case MMS, ex vivo, suggesting that diets 
with compounds rich in ursolic acid can ameliorate the individual’s health, protecting 
against different types of DNA damage, reducing risk of DNA damage-associated 
diseases. 
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Figure 12 – Endogenous (A) and MMS (B)-induced DNA damage in isolated colonocytes. Test compounds 
were given in the diet for two weeks, two natural compounds - ursolic acid (UA) and (-)-epigallocatechin 
gallate (EGCG), and deoxycholic acid (DCA). DNA damage was measured by the comet assay. Results are 
expressed as percentage of control. *P ≤ 0.05, ** P≤ 0.01, when compared with respective control, #P≤ 
0.05 when compared with DCA treatment alone was determined by student’s t-test. 
 
 
Figure 13 – Endogenous (A) and MMS (B)-induced DNA damage in isolated lymphocytes. Test 
compounds were given in the diet for two weeks, two natural compounds - ursolic acid (UA) and (-)-
epigallocatechin gallate (EGCG), and deoxycholic acid (DCA). DNA damage was measured by the comet 
assay. Results are expressed as percentage of control. *P ≤ 0.05 when compared with respective control, 
#P≤ 0.05 when compared with DCA treatment alone was determined by student’s t-test. 
 
As pointed out previously, the types of DNA damage induced in this study are 
repaired by the base excision repair system. The protein expression of three intervenients 
in this repair system was evaluated in the isolated colonocytes and lymphocytes. We 
found no differences in the expression of APE1 and MPG proteins (data not shown), but 
found a decrease in OGG1 expression by UA and EGCG (Figure 14). OGG1 (the human 
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equivalent of FPG) recognizes oxidation damage, specifically 8-oxoguanine. In 
colonocytes, levels of 8-oxoguanine recognized by using the FPG enzyme were decreased 
by our natural compounds, so we can hypothesize that the ability of UA and EGCG to 
decrease OGG1 protein expression is related with the protective effect against DNA 
damage. It is known that transcription of BER genes is regulated by the cell cycle and by 
oxidative stress [Tudek, B., 2007]. If both compounds exert their antioxidant properties 
by reducing the levels of DNA damage, then OGG1 is not needed to recognize the lesions, 
therefore, the production of this protein is basal, hence explaining the decreased 
expression of OGG1 when compared with the control group. In lymphocytes, the levels 
of FPG sites are low to begin with (around 15% in the control group) possibly explaining 
the lack of protection by our natural compounds, nevertheless, the compounds are present 
and there can also be a reduction of expression of OGG1. Although bile acids are known 
to increase ROS production and therefore increase DNA damage, in our study 
deoxycholic acid did not affect DNA damage in any way, nor protein expression.  
Although some of the effects observed in colonocytes were also found with 
lymphocytes, the susceptibility of the two cell types is different, so there are not enough 
results to authenticate lymphocytes as surrogate markers. Nevertheless, ursolic acid and 
EGCG were found to decrease DNA damage, possibly by their antioxidant potential, 
ameliorating the basic internal status of colonocytes and lymphocytes. Consumption of 
fruits and vegetables with these compounds could therefore benefit public health by 
countering oxidative stress factors and help prevent diseases mediated by ROS-induced 
DNA damage.  
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Figure 14 – Expression of OGG1 protein in colonocytes (A) and lymphocytes (B) isolated from rats. 
Protein expression was assayed by western blot. Results are expressed as percentage of control. *P ≤ 0.05 
and **P ≤ 0.01 when compared with respective control determined by one-way ANOVA followed by 
Tukey’s post-test. 
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1 – An epigenetic application for the CoMeth assay 
 
1.1 – Introduction 
  
Colorectal cancer (CRC) arises from an accumulation of genetic and epigenetic 
alterations. Epigenetics is the regulation of gene expression without modification of the 
DNA sequence. This regulation can be done by DNA methylation in promoter regions, 
histone modifications regulating transcription or noncoding RNAs. DNA methylation is 
the most studied epigenetic modification in humans. Cytosine methylation consists of a 
covalent addition of a methyl group from a methyl donor to a cytosine within a CpG 
dinucleotide by a specific family of enzymes, the DNA methyltransferases (DNMTs). 
These CpG dinucleotides are usually found in small clusters, called CpG islands. In 
cancer cells, DNA methylation is affected by two major alterations: (1) a global 
hypomethylation of the DNA due to generalized demethylation in the scattered CpG 
islands in the genome, allowing transcription of otherwise silenced oncogenes, and (2) 
specific promoter regions of tumor-suppressor genes are hypermethylated, inhibiting 
gene transcription [Goel, A., et al., 2012; Kulis, M., et al., 2010; Sandoval, J., et al., 2012].  
 Nowadays, the term “CpG island methylator phenotype” or CIMP, is a 
characteristic of tumors in which tumor suppressor genes are silenced by 
hypermethylation, and tumor progression occurred, at least in part, by progressive tumor 
silencing. The most common silenced genes in CRC are PTEN, MLH1, MSH2, APC, 
RUNX3 (a transcription factor), UNC5C (involved in cell migration) and MGMT. The 
mismatch repair gene MLH1 was one of the first important tumor suppressor genes to be 
seen hypermethylated in cancer. Lynch syndrome (formerly known as hereditary 
nonpolyposis colorectal cancer, or HNPCC) arises due to mismatch repair dysfunction 
and hypermethylation of hMLH1 and hMSH2. hMLH1 has also been found silenced in 
sporadic cases of CRC [Goel, A., et al., 2012].  
Different from irreversible gene mutations, epigenetic silencing can be reactivated 
by small molecules that act as epigenetic modifiers. These epigenetic modifiers can 
interfere with the activity of DNMTs, histone deacetylase (HDAC), and sirtuins, a 
specific class of histone acetyltransferases (HATs). Inhibiting DNMT’s can reverse 
hypermethylation by covalently trapping DNMT after incorporation in the DNA strand, 
blocking the catalytic site of the enzyme, degradation of the enzyme, or suppression of 
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the enzyme expression. 5-azacytidine (5-aza) is incorporated in the DNA and DNMT 
activity is lost due to the enzyme becoming irreversibly bound to 5-aza residue in the 
DNA, and this leads to loss of methylation [Christman, J.K., 2002]. Some natural 
compounds have already been found to reverse hypermethylation in cells [Banno, K., et 
al., 2012; Pezzuto, J.M., et al., 2013]. For example, epigallocatechin gallate was found to 
bind to the catalytic site of DNMT, therefore inhibiting DNMT activity, and reactivating 
silenced genes in cell lines [Fang, M.Z., et al., 2003]. Reversing hypermethylation of 
promoter regions by demethylating compounds is an interesting approach for cancer 
prevention as well as therapy. In therapy, epigenetic agents may be used as sensitization 
agents to overcome CRC drug resistance or to directly modulate an epigenetic alteration 
for therapeutic intervention [Bardhan, K., et al., 2013].  
 In this study, we developed a new adaption to our CoMeth assay, for epigenetic 
agent screening that act on DNMT inhibition. We used a colorectal cancer cell line (RKO) 
with hMLH1 silencing by promoter hypermethylation, reactivated the expression of the 
protein with a well-known demethylating compound, 5-azacytidine, and used the CoMeth 
assay to see strand breaks. After characterization of the method, by nuclear condensation 
and western blot analysis, we used some natural compounds in our adapted CoMeth assay 
to screen for potential epigenetic chemopreventive compounds. 
 
1.2 – Material and methods 
 
1.2.1 – Reagents, plant material and antibodies 
N-Methyl-N-nitrosourea (MNU), O6-benzylguanine (BG), thiazolyl blue 
tetrazolium bromide (MTT), 5-aza, (-)-epigallocatechin gallate (EGCG), curcumin, 
ursodeoxycholic acid, resveratrol, ursolic acid, rosmarinic acid, RPMI - 1640 medium, 
penicillin/streptomycin, and trypsin solution were purchased from Sigma–Aldrich (St. 
Louis, MO, USA). Fetal bovine serum (FBS) was purchased from Biochrom KG (Berlin, 
Germany). SYBR Gold (nucleic acid gel stain) was from Invitrogen Molecular Probes 
(Eugene, OR, USA). The protein quantification DC protein assay was purchased from 
Bio-Rad Laboratories (Hercules, CA, USA). Primary antibodies were purchased from the 
following sources: anti-actin was purchased from Sigma–Aldrich; anti-p53, anti-MGMT 
and anti-MLH1 Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Peroxidase-
conjugated goat anti-mouse antibody and Immobilon Western blotting detection reagents 
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and Millipore 
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(Billerica, MA, USA), respectively. All other reagents and chemicals used were of 
analytical grade. 
Salvia officinalis L. plants was from an experimental farm in Arouca, Portugal. 
Plants were collected between 2001 and 2003 and the water extracts were prepared as 
described previously by our group [Lima, C.F., et al., 2005]. The filtered water extract 
was then lyophilized to dryness, giving a yield of 25.8%, and stored at -20 ºC.  
 
1.2.2 – Cell line and culture conditions 
RKO cells, derived from human colon carcinoma were a gift from Dr. Raquel 
Seruca (IPATIMUP, University of Porto, Portugal) and were maintained as monolayer 
cultures in RPMI medium supplemented with 10% FBS and antibiotics (100 U/mL 
penicillin and 100 mg/mL streptomycin), under an atmosphere of 5% CO2 at 37 ºC. Cells 
were seeded onto 6- (2 mL) or 12- (1 mL) well plates at a density of 0.2×105 cells/mL. 
Test compounds were added to culture medium to the desired concentration ensuring that 
the DMSO concentration did not exceed 0.5% (v/v); controls received vehicle only. 
 
1.2.3 – Assessment of cell viability/proliferation by MTT reduction test 
A MTT reduction assay was performed in order to evaluate the toxicity of 5-
azacytidine in the RKO cell line. Cells were treated with different concentrations (0.5, 1, 
and 2 µM) of the 5-aza for 72 an 96 h, including 2 h incubation with MTT (final 
concentration 0.5 mg/mL). The formazan crystals were then dissolved in a solution of 
DMSO/ethanol (1:1). The number of viable cells in each well was estimated by the cell 
capacity to reduce MTT. The results were expressed as percentage relative to the control 
(cells without any compound). 
 
1.2.4 – Adaptation of the CoMeth assay 
The CoMeth assay [Ramos, A.A., et al., 2013] was developed by our group to 
measure O6MeG lesion in DNA. This assay can only be used in a cell line with a 
functional mismatch repair system, to be able to start repair and induce strand breaks. In 
a cell line that has a silenced MLH1 gene, demethylating compounds revert this effect and 
the CoMeth assay is functional. So, we developed a new adaptation of the CoMeth assay 
to study demethylating compounds. We used a known demethylating compound, 5-
azacytidine, to revert MLH1 silencing in RKO cell line. Briefly, cells were treated with 
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5-azacytidine for 48 h before treatment with BG, 100 µM, for 2 h and MNU (500 µM) 
for 24 or 48 h. 5-azacytidine was also added in these incubations.  
Afterwards, the alkaline version of the single cell gel electrophoresis (comet) 
assay was used to evaluate DNA damage [Collins, A.R., 2004]. Cells were collected by 
trypsinization and around 50,000 cells were centrifuged for 1 min at 5,000 rpm, 
ressuspended in low melting point agarose and spread onto agarose-coated slide using a 
cover slip. After 10 min at 4 ºC, the coverslips were removed and slides were placed in 
lysis solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris base, pH 10, plus 1% Triton 
X-100) for 1 h at 4 ºC. Slides were then placed in a horizontal electrophoresis chamber 
with electrophoresis solution (0.3 M NaOH, 1 mM Na2EDTA, pH > 13) for 40 min at 4 
ºC for the DNA to unwind before electrophoresis for 20 min at 0.8 V/cm and ∼300 mA. 
After electrophoresis, slides were washed twice with PBS and dried at room temperature. 
For analysis of the comet images, slides were stained with SYBR Gold solution for 30 
min at 4 ºC; after drying, the slides were analyzed using a fluorescence microscope and 
the Comet IV analysis system (Perceptive Instruments Ltd, Haverhill, UK) was used to 
calculate the parameter percentage of DNA in the tail. About 100 randomly selected cells 
were analyzed per sample. 
For the screening of natural compounds, the same protocol was used, substituting 
5-azacytidine for the natural compounds tested: (-)-epigallocatechin gallate (EGCG) – 4 
µM, curcumin - 3 µM, ursodeoxycholic acid - 500 µM, resveratrol – 20 µM, rosmarinic 
acid - 20 µM, ursolic acid - 4 µM, Salvia officinalis (SO) – 50 µg/mL. Cells were treated 
with the compounds for 48 h before treatment with or without BG, 100 µM, for 2 h and 
MNU (500 µM) for 48 h. Afterwards, the comet assay was used to evaluate DNA damage, 
as described before.  
 
1.2.5 – Nuclear condensation assay 
The effects of the conditions of the modified CoMeth assay on cell death in RKO 
cells. The number of apoptotic cells was counted after 48 and 72 h as previously described 
[Xavier, C.P., et al., 2009]. At least 500 cells were counted and the number of apoptotic 
cells was divided by the total number cells counted to give the percentage of cell death.  
 
1.2.6 – Western blot analysis 
RKO cells were treated with 5-azacytidine for 48 h before treatment with or 
without BG, 100 µM, for 2 h and MNU (500 µM) for 24 or 48 h. 5-azacytidine was also 
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added in these incubations. Total cell lysates were prepared to measure expression of 
different proteins. The cells were washed with PBS 1x and lysed for 5 min at 4 °C with 
ice-cold RIPA buffer (1% NP-40 in 150 mM NaCl, 50 mM Tris (pH 7.5), 2 mM EDTA) 
supplemented with 20 mM NaF, 1 mM phenylmethylsulfonyl fluoride, 20 mM Na3VO4 
and protease inhibitor cocktail (Roche, Mannheim, Germany). Protein concentration was 
quantified using the DC protein assay following the manufacturer’s instructions, and 20 
µg/well was separated by 12% SDS–PAGE and transferred to polyvinylidene difluoride 
membranes. Membranes were blocked and incubated with primary antibody overnight. 
After washing, membranes were incubated with secondary antibody conjugated with IgG 
horseradish peroxidase for 1 h, and immunoreactive bands were detected using the 
Immobilon solutions (Millipore, Billerica, MA, USA) under a chemiluminescence 
detection system (Chemi Doc XRS; Bio-Rad Laboratories, Inc.). 
Band area intensity was quantified using the Quantity One software from Bio-Rad. 
β-Actin was used as loading control. 
 
1.2.7 – Statistical analysis 
Statistical analyses were done using t-test, one-way or two-way analysis of 
variance using GraphPad Prism 4.0 software, when appropriate (San Diego, CA, USA). 
P values ≤0.05 were considered statistically significant. All results are presented as mean 
± SEM of at least three independent experiments. Images are representative of three 
independent experiments. 
 
1.3 – Results and discussion 
 
In this study, a novel assay for screening compounds with potential demethylating 
capacity using the simple comet assay was developed. This method uses the adapted 
CoMeth version of the comet assay, developed by our group [Ramos, A.A., et al., 2013]. 
The CoMeth assay is based on the principal that in a condition when MGMT is inhibited, 
for example with BG, and a compound, in this case MNU, induces the O6methylguanine 
lesion, a functional mismatch repair system will recognize and start to repair the lesion, 
introducing nicks in the DNA strand. These nicks will be detected by the comet assay. In 
this new version, instead of using a mismatch repair functional cell line, as needed for the 
CoMeth assay, we use a hMLH1 silenced cell line, that will not present comets in response 
to MNU due to the lack of functional mismatch repair. Theoretically, if we use a 
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demethylating agent and reactivate MLH1 expression, we have a functional mismatch 
repair system and will observe an increase in DNA strand breaks. The demethylating 
compound 5-azacytidine was used to test our hypothesis.  
First, we tested for toxicity of the compound, as the objective is to increase strand 
breaks by activating the mismatch repair system and not due to direct toxicity of our test 
compound. For this, we measured cell viability using the MTT assay with 0.5, 1 and 2 
µM of 5-azacytidine for 72 and 96 h incubation (Figure 1). This compound showed no 
decrease in cell viability at 72 or 96 h incubation, proving that these concentrations are 
not cytotoxic for these cells.  
The concentration of 2 µM of 5-azacytidine was used in the subsequent assays. 
For the adapted epigenetic version of the CoMeth assay, cells were treated with 5-
azacytidine for 48 h before incubation with BG and MNU. We found that at 24 h 
incubation of MNU there were no significant differences between treatment with BG + 
MNU and 5-aza + BG + MNU, but at 48 h incubation with MNU there is a significant 
increase of DNA damage with the 5-azacytidine treatment (Figure 2). The difference, at 
this time point, between BG + MNU and 5-aza + BG + MNU are cells that now have 
functional mismatch repair systems (MLH1 is no longer silenced and there is transcription 
of the protein) and recognize the O6-methylguanine lesion induced by MNU, generating 
strand breaks detected by the comet assay.  
 
 
Figure 1 – The effect of different concentrations of 5-azacytidine on cell viability at 72 (white bars) and 
96 (gray bars) h incubation, in RKO cells. Cell viability was measured by the MTT assay and results are 
the mean ± SEM of at least 3 independent experiments. *P≤ 0.05 when compared with respective control 
was determined by one-way ANOVA followed by Newman-Keuls multiple comparison test. 
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 In this system, cell death is induced due to the recognition of unrepaired 
O6methylguanine lesion by the mismatch repair system. This repair system introduces 
strand breaks by excising the mispair created by the lesion, but as long as the 
O6methylguanine remains in the DNA template, this process will be repeated, creating a 
futile repair loop that results in double strand breaks and, consequently, cell death [Kaina, 
B., et al., 2007; Kondo, N., et al., 2010]. This only happens if the MMR system is 
functional. At 72 and 96 h incubation, it was possible to observe a significant increase in 
cell death with 5-azacytidine + BG + MNU when compared with control (Figure 3). This 
increase in cell death was not seen in the condition with BG + MNU alone because MLH1 
is silenced and the mismatch repair is not functional. This increase in cell death is 
additional proof that the mismatch repair system is functional after 5-aza treatment. So, 
there is an increase of DNA damage when 5-azacytidine is used in the RKO cell line and 
this DNA damage leads to cell death at 96 h.  
 
 
Figure 2 – Modified CoMeth assay for epigenetic screening of demethylating compounds. Cells were 
incubated with 5-azacytidine for 48 h before 2 h incubation with BG and 24 or 48 h incubation with MNU. 
DNA damage was then measured with standard comet assay and results are the mean ± SEM of at least 3 
independent experiments.. *P≤ 0.05, ##P≤ 0.01, ### P≤ 0.005 when compared with respective control and 
+ P≤ 0.05, were determined by one-way ANOVA followed by Newman-Keuls multiple comparison test. 
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Figure 3 – Effects of the conditions of the modified CoMeth assay on cell death. Cells were incubated with 
5-azacytidine for 48 h before 2 h incubation with BG and 72 (white) or 96 (gray) h incubation with MNU. 
Cell death was measured by nuclear condensation assay and results are the mean ± SEM of at least 3 
independent experiments.. *P≤ 0.05 and ### P≤ 0.005 when compared with respective control were 
determined by one-way ANOVA followed by Newman-Keuls multiple comparison test. 
 
 MLH1 and MGMT protein expression were also evaluated. In this assay, BG is 
added to the cells for MGMT inhibition. MGMT is responsible for the repair of the O6-
methylguanine lesion, but this protein is a suicide repair enzyme, in which, after the 
transfer of the alkyl group from the DNA template to a cysteine residue in the active 
center of the molecule, this enzyme is inactivated and directed to the proteasome for 
degradation. BG acts as a pseudosubstrate of MGMT, thus inactivating the enzyme 
[Srivenugopal, K.S., et al., 1996]. By western blot, we found that all the conditions that 
received BG had almost no expression of the protein, confirming that in this assay, this 
concentration of BG is sufficient to inhibit almost all of MGMT protein during 48 h 
incubations (Figure 4).  
As MGMT is inactive, the mismatch repair system recognizes the unrepaired O6-
methylguanine lesion induced by MNU, as long as it is functional, which in this case is 
with 5-azacytidine incubation. Treatment with 5-azacytidine alone increase MLH1 
expression when compared with the respective control at 24 h (Figure 4). When 5-aza 
treatment is not given, the levels of MLH1 protein are similar to the control. The 
demethylating agent is able to increase the expression of the silenced MLH1 protein, 
activating the mismatch repair system. These results suggest that treatment with 5-aza for 
48 h reactivates the expression of MLH1 protein. When BG is used to inactivate MGMT 
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and MNU induces O6-methylguanine lesion, in cells with reactivated MLH1, there is an 
increase of DNA damage observed by the comet assay, after 48 h treatment with MNU, 
and increase in cell death at 72 and 96 h incubations. 
The p53 protein is referred to as the “guardian of the genome” as its role is to 
respond to DNA damage and pause the cell cycle, to allow repair, or upregulate proteins 
involved in cell death pathways. TP53 mutations are very common in colorectal cancers, 
but usually appear in late stages of the carcinogenic process [Pezzuto, J.M., et al., 2013]. 
The RKO cell line is P53 wild-type and, in this study, the effect of the conditions used on 
the modified CoMeth assay on p53 protein expression were evaluated (Figure 5). 
Interestingly, we found a significant increase of p53 expression with the 5-azacytidine 
treatment alone at both time points. This increase could possibly be explained by the 
expression of another protein, the death-associated protein kinase (DAPK). DAPK is a 
serine/threonine kinase involved in the extrinsic death receptor-mediated apoptotic 
pathway. There is an autoregulatory feedback loop between DAPK and p53, as DAPK is 
induced by p53 activation and DAPK expression increases p53 protein expression. It is 
known now that DAPK promoter is usually hypermethylated in many cancers [Gozuacik, 
D., et al., 2006; Pezzuto, J.M., et al., 2013], and the RKO cell line presents this promoter 
hypermethylation [Paz, M.F., et al., 2003]. This increase of p53 expression could be 
explained by the re-expression of DAPK protein by 5-azacytidine and the regulatory 
feedback loop. There was also an increase of p53 protein expression with MNU treatment 
alone at 24 h incubation. As in this condition MGMT is not inhibited by BG, this increase 
could be due to normal molecular p53-dependent signaling due to the repair of DNA 
damage, induced by MNU, by MGMT [Roos, W., et al., 2004]. P53 has been found to be 
involved in DNA repair in the cells. After the introduction of DNA injuries the level of 
p53 protein rises, which in turn induces a transient cell cycle arrest or apoptotic cell death. 
Also, some mismatch repair proteins are p53 target genes, including MSH2 and MLH1 
[Gatz, S.A., et al., 2006]. So, this increase of p53 expression can also regulate mismatch 
repair, inducing transcription of the mismatch repair proteins and increasing apoptosis, 
an effect that we also observed. 
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Figure 4 – Effects of treatment with the conditions of the modified CoMeth on MLH1 and MGMT protein 
expression in RKO cells, using western blot. Cells were incubated with 5-azacytidine for 48 h before 2 h 
incubation with BG and 24 h incubation with MNU. β-actin was used as loading control. Values are mean 
± SEM of at least three independent experiments. *P ≤ 0.05 when compared to control. 
 
 Until now, it seems that the assay is effective, so we used this method to 
investigate the potential of natural compounds to be demethylating compounds (Figure 
6). Of all the compound, (-)-epigallocatechin gallate (EGCG) presented values very 
similar with our positive control, 5-azacytidine. It is known that EGCG has DNMT 
inhibiting capacity [Fang, M.Z., et al., 2003; Nandakumar, V., et al., 2011], so this result 
can confirm that our modified CoMeth assay can be used to screen demethylating 
compounds. Of the other natural compounds, resveratrol also showed results similar to 
our positive control and this compound has been shown to have demethylating potential 
in breast cancer cells [Paluszczak, J., et al., 2010]. Further studies on MLH1 protein 
expression with these natural compounds are needed to validate the effects in the comet 
assay.  
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Figure 5 – Effects of treatment with the conditions of the modified CoMeth on p53 protein expression in 
RKO cells, using western blot. Cells were incubated with 5-azacytidine for 48 h before 2 h incubation with 
BG and 24 and 48 h incubation with MNU. β-actin was used as loading control. Values are mean ± SEM 
of at least three independent experiments. **P≤ 0.01, ***P≤ 0.005, and ### P≤ 0.005 when compared with 
respective control were determined by one-way ANOVA followed by Newman-Keuls multiple comparison 
test. 
 
 In conclusion, we developed a modified version of the comet assay to evaluate 
potential compounds with demethylating capacity. The comet assay is a simple, relatively 
cheap assay to evaluate DNA damage. The standard version is capable to evaluate strand 
breaks and different versions of this assay have been developed to increase the types of 
damage that are possible to assess. Our lab has developed a version to evaluate the 
alkylating DNA damage, O6methylguanine. With this in mind, and using a mismatch 
repair deficient cell line in which MLH1 is epigenetically silenced, we were able to 
present a method to investigate potential demethylating compounds. We characterized 
this method using a well-known demethylating agent, 5-azacytidine, and also showed the 
application with natural compounds for screening purposes. This assay should be 
accompanied by a protein expression assays to ensure that the effects seen are due to the 
demethylating potential and reexpression of the protein. Further studies will be done to 
validate this method.  
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Figure 6 – Modified CoMeth assay for epigenetic screening of demethylating compounds. Cells were 
incubated with tested compounds or 5-azacytidine for 48 h before 2 h incubation with BG and 24 or 48 h 
incubation with MNU. . Concentrations used were: (-)-epigallocatechin gallate (EGCG) – 4 µM, curcumin 
(CUR) - 3 µM, ursodeoxycholic acid (UDCA) - 500 µM, resveratrol (RES) – 20 µM, rosmarinic acid (RA) 
- 20 µM, ursolic acid (UA) - 4 µM, Salvia officinalis (SO) – 50 µg/mL. DNA damage was then measured 
with standard comet assay and results are the mean ± SEM of at least 3 independent experiments.  
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1 – General conclusions 
 
Colorectal cancer is a major health problem, as it is one of the most common types 
of cancer in Western societies. The accumulation of genetic and epigenetic alterations 
transforms normal colon cells and gives them growth advantage over their neighboring 
cells. These genomic alterations and mutations can alter the cell’s behavior, in the 
initiation and/or progression process, and how the tumor will respond to therapy, in cancer 
treatment. Colorectal cancer is highly associated with lifestyle, such as obesity, lack of 
physical activity, smoking habits, and most importantly, diet. Diet has an important role 
not only on the initiation of the disease, but also in possible chemopreventive and 
therapeutic strategies. Diet may have adverse effects on colon cancer, being one of the 
main risk factors of this disease. High intake of saturated fat, red meat, and processed 
foods has been linked to increase in cancer risk. Fruits and vegetables, and isolated 
compounds of these foods, have shown to be promising agents that may play a role in 
cancer prevention as well as in cancer therapy. Modulation of signaling pathways 
associated with proliferation and apoptosis, protection against DNA damage, and 
induction of DNA repair are just some of the possible mechanisms of action for cancer 
prevention. 
The main objective of this work was to evaluate the effect of some dietary 
compounds on colon cancer prevention and bile acids in colon cancer promotion. In 
Chapter 2, the effects of two bile acids, deoxycholic acid and ursodeoxycholic acid, were 
evaluated in colon cancer cell line with no mutations in the MAPK and PI3K/AKT 
pathways. Deoxycholic acid is considered a colon cancer promoter, while 
ursodeoxycholic acid is used in studies to evaluate chemoprevention. In this study, 
deoxycholic acid was found to decrease proliferation and induce apoptosis with high 
concentrations (500 µM). This induction of apoptosis could be due, in part, to formation 
of reactive oxygen species and/or induction of DNA damage that was observed with 
deoxycholic acid. Ursodeoxycholic acid did not induce any of these alterations. It is 
known that bile acids can regulate DNA repair proteins, so with this in mind, the effects 
of these bile acids on MLH1, a mismatch repair protein, and MGMT protein expression 
were evaluated. Both bile acids were able to decrease the expression of these proteins 
after 48 h incubation. This effect suggests that these two bile acids can promote 
carcinogenesis through reduction of DNA repair. The activation of three signaling 
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pathways was also determined. The bile acids were able to activate PI3K/AKT and 
MAPK/ERK by increase of phosphoAKT and phosphoERK expression, respectively, but 
not JNK signaling pathway. As ursodeoxycholic acid is believed to be chemopreventive, 
the effect of pretreatment of this compound before DCA treatment was also evaluated. In 
this study, we found an increase of cell death with the pretreatment of ursodeoxycholic 
acid when compared with deoxycholic acid alone. This increase of apoptosis was 
accompanied by a constant activation of the JNK signaling pathway, determined by 
phosphoJNK protein expression. Also, pretreatment with ursodeoxycholic acid 
significantly decreased expression of the repair proteins MGMT and MLH1. Deoxycholic 
acid induced typical alterations associated with cancer promotion. On the other hand, 
ursodeoxycholic acid did not show any effects of chemopreventive potential and even 
enhanced deoxycholic acid apoptosis and decreased DNA repair protein expression. 
In chapter 3, we tried to develop an in vitro model of azoxymethane-induced colon 
carcinogenesis. The characterization of the effects induced were compared to the 
alterations induced in the in vivo model. For this, we used the Caco-2 cell line and added 
a S9 liver fraction mixture to enhance azoxymethane metabolization. Azoxymethane (15 
µM) treatment for 48 h slightly increased cell proliferation and phosphoERK expression. 
On the other hand, no DNA damage was observed, oxidative or O6meG, whereas 
azoxymethane induces the O6meG lesion in vivo. Also, no nuclear translocation of β-
catenin was observed. The lack of consistencies with the in vivo assay suggest the 
optimization of the in vitro assay. 
Chapter 4 was dedicated to the in vivo effects of natural compounds on colon 
cancer prevention. In the first part, the effect of an herbal tea, Salvia officinalis, was 
evaluated on the prevention of colon carcinogenesis used the in vivo AOM-induced 
model. In this study, our herbal tea reduced the number of pre-neoplastic lesions induced 
by AOM. This reduction was accompanied by a decrease of Ki67 staining, suggesting an 
effect of Salvia officinalis on cell proliferation, an effect already seen in vitro by our 
group. Herbal tea drinking did not effect metabolization or elimination of azoxymethane 
in the liver, as there were no effects on CYP2E1 expression and activity, nor GSH and 
GST activity. Azoxymethane induced DNA damage in colonocytes and lymphocytes and 
Salvia officinalis drinking protect colonocytes and lymphocytes from this DNA damage. 
Also, H2O2 was used to induce DNA damage ex vivo to colonocytes and lymphocytes 
isolated from rats that drank the herbal tea and that drank water, and Salvia officinalis 
protected against this type of DNA damage. In the second part, we evaluated the effects 
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of two isolated compounds, ursolic acid and (-)-epigallocatechin-gallate, on protection 
against DNA damage in healthy animals. The comparison of the effects on lymphocytes 
and colonocytes for the possible use of lymphocytes as surrogate markers of effects on 
colonocytes, but the data collected was not sufficient to validate this hypothesis. The 
natural compounds tested protected against endogenous DNA damage, in colonocytes 
and lymphoctyes. When an alkylating agent was used ex vivo, MMS, ursolic acid and (-
)-epigallocatechin-gallate protected against this type of damage in colonocytes, but not in 
lymphocytes. The expression of a base excision repair protein, OGG1, was evaluated by 
western blot and both natural compounds were found to decrease the expression of this 
protein. This could be explained by the fact that if the compounds exert their antioxidant 
properties by reducing the levels of DNA damage to begin with, then there is no need to 
increase the transcription levels of the protein. So in this section we demonstrated the 
potential of an herbal tea and two isolated dietary compounds to protect against colon 
carcinogenesis. In this study, DCA was also used, but it did not induce DNA damage 
itself or increase DNA damage induced by MMS.  
In chapter 5, we adapted a version of the CoMeth assay to be used for screening 
of epigenetic compounds with DNMT inhibiting potential. We used a hMLH1 silenced 
cell line and reactivated the expression of the protein by using 5-azacytidine. We then 
used BG and MNU, as in the CoMeth assay, to inactivate MGMT and induce the 
O6methylguanine lesion. The difference of DNA damage we found between treatment 
with 5-aza + BG + MNU and BG + MNU alone is DNA damage induced by the 
reactivation of hMLH1, proving that the compound tested, in this case a well-known 
demethylating agent, has demethylating activity. We further characterized this model by 
observing the induction of cell death after 72 and 96 h incubation with the 5-aza + BG + 
MNU, typical phenotype of MMR proficient cells with inhibited MGMT and 
O6methylguanine lesion corrected by the MMR system. By western blot, we observed 
efficient inhibition of MGMT by BG and transcription of MLH1 protein by 5-aza. We 
also observed an increase of p53 protein with 5-aza treatment. This increase could be 
explained by the reactivation of DAPK, also found silenced, and an autoregulatory 
feedback loop with p53. We further tested several natural compounds and their ability to 
act as demethylating agents. By the comet assay, we observed that EGCG showed DNA 
damage levels similar to 5-aza. It is known that EGCG is an inhibitor of DNMT activity, 
and therefore a demethylating agent, so this helps to further validate our assay. 
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In conclusion, this work demonstrates the chemopreventive effects of natural 
compounds, Salvia officinalis tea, ursolic acid and EGCG. These compounds protect 
against DNA damage and show colorectal cancer chemopreventive activity. We also 
demonstrated the deleterious effects of deoxycholic acid and ursodeoxycholic acid and 
characterized the molecular alterations induced by these bile acids. Not only does DCA 
promoter cell turnover, it inhibits DNA repair proteins, enhancing its tumor promoting 
ability. UDCA inhibits DNA repair proteins and enhances DCA-induced apoptosis. 
Finally, we developed a new adaptation of the comet assay to detect possible 
demethylating compounds. More studies are needed to safely add these compounds to 
dietary strategies for colorectal cancer prevention. 
  
2 – Further perspectives 
 
The studies presented in this thesis were carried out to increase our knowledge in 
dietary compounds that can be inserted into dietary strategies for cancer prevention. 
Despite all the work presented here, many questions remained unanswered and many 
more appeared. 
The studies with DCA demonstrated increase of apoptosis, increase of DNA 
damage and increase of signaling pathways that control cell proliferation. It has been 
demonstrated elsewhere that low and high concentrations of DCA have different effects 
on cell proliferation. Studies with lower concentrations of DCA to compare with the 
effects of high concentrations would give more information on the effects of this bile acid 
in colon carcinogenesis. The preventive effects of UDCA before DCA needs further 
investigation. The effects presented in this thesis are different from the idea that UDCA 
is preventive. More studies with different concentrations and different time points could 
help clarify this inconsistency. 
We tried to develop an in vitro model of the AOM-induced colorectal 
carcinogenesis using Caco-2 cell line. The effects found with the conditions tested did 
not correlate with the alterations found in the in vivo model. Evaluation of the effect of 
longer periods of incubation with AOM to verify if longer time points are needed to 
develop this in vitro model. Also, we can use BG before AOM exposure and evaluate 
MAPK pathway and if there is induction of alterations in this pathway. If it is possible to 
develop the model, using natural compounds to prevent AOM alterations in vitro for 
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screening processes. The most promising compounds can then be used in the in vivo 
model to verify if the effects seen in vitro are also seen in vivo. 
In chapter V, we developed a method to study possible demethylating agents. 
Further studies are needed to validate this method. MS-PCR could be done to verify the 
reactivation of MLH1 expression in the model. Also, 72 and 96 h incubations for the 
comet assay could be done to see if the effect is more pronounced with longer periods of 
incubation. Also, western blot of the natural compounds + BG + MNU should be done to 
observe the expression of MLH1 protein.  
 
 
